Vulvovaginal ulceration/inflammation in other diseases

N14_VULVOVAGINFINOTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N77* Cause of death: ICD-10 — N77* 2 out of 7 registries used, show all original rules.	2601
4. Check minimum number of events None	2601
5. Include endpoints None	2601
6. Filter based on genotype QC (FinnGen only)	2493

Control definitions (FinnGen only)

Control exclude: N14_FEMALEGENINF

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	N14_VULVOVAGINFINOTH
CONTROL_EXCLUDE	N14_FEMALEGENINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N77
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N77
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Vulvovaginal ulceration/inflammation in other diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Vaginal lichen planus

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13884	13884	-
Only index persons	13459	13459	-
Unadjusted period prevalence (%)
Whole population	0.40	0.40	-
Only index persons	0.49	0.49	-
Median age at first event (years)
Whole population	-	30.72	-
Only index persons	-	30.83	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2493	2493	-
Unadjusted period prevalence (%)	0.88	0.88	-
Median age at first event (years)	36.69	36.69	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2601: Matched controls
26010

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

127.5

307.7

462

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

65.0

307.7

1147

312

N77.0*A60.0

ICD-10 Finland

Ulceration of vulva in herpesviral [herpes simplex] infection

79.9

307.7

213

N77.1

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere

86.6

307.7

718

114

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

11.4

284.0

311

305

J02AC01

ATC

fluconazole; systemic

4.8

280.3

1963

10157

N76.0

ICD-10 Finland

Acute vaginitis

5.1

239.8

598

1429

J05AB01

ATC

aciclovir; systemic

3.6

210.6

1040

4049

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

9.2

183.1

231

272

N77.8*L43.9

ICD-10 Finland

Vulvovaginal ulceration and inflammation caused by lichen ruber planus

328.5

181.6

182

J05AB11

ATC

valaciclovir; oral

3.7

168.6

691

2339

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

4.4

155.6

443

1154

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

10.6

142.7

160

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

9.3

136.3

168

191

ULA02

NOMESCO Finland

Kolposcopy

3.2

125.5

632

2387

N77.0

ICD-10 Finland

Ulceration of vulva in infectious and parasitic diseases classified elsewhere

58.7

112.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.5

108.0

1086

5792

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

6.2

102.7

184

318

P01AB01

ATC

metronidazole; oral, rectal

2.4

102.1

1329

7901

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

5.9

101.7

190

342

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.4

98.7

1358

8231

N76.3

ICD-10 Finland

Subacute and chronic vulvitis

13.6

96.7

L43.9

ICD-10 Finland

Lichen planus, unspecified

8.6

96.4

125

151

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.5

88.7

711

3358

J02AC02

ATC

itraconazole; systemic

2.6

82.4

618

2817

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

10.1

82.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

81.2

1256

7786

D07AD01

ATC

clobetasol; topical

2.6

80.2

564

2489

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.4

69.4

590

2825

G01AA10

ATC

clindamycin; vaginal

2.3

66.5

674

3473

N76.2

ICD-10 Finland

Acute vulvitis

11.5

61.4

D06BB03

ATC

aciclovir; topical

3.7

60.3

206

598

N76.6

ICD-10 Finland

Ulceration of vulva

10.1

58.8

L29.2

ICD-10 Finland

Pruritus vulvae

4.9

58.8

132

279

N77.8

ICD-10 Finland

Vulvovaginal ulceration and inflammation in other diseases classified elsewhere

201.1

57.2

L43.8

ICD-10 Finland

Other lichen planus

6.6

55.5

140

J01EA01

ATC

trimethoprim; systemic

2.0

53.1

890

5462

J01MA02

ATC

ciprofloxacin; systemic

1.9

51.7

893

5525

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

4.0

51.6

152

397

N30.9

ICD-10 Finland

Cystitis, unspecified

3.0

50.8

244

871

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

4.6

49.3

121

275

LEB00

NOMESCO Finland

Biopsy of vagina

5.1

47.9

102

206

R30.0

ICD-10 Finland

Dysuria

3.4

47.8

177

540

J01CA08

ATC

pivmecillinam; oral

1.8

45.5

1524

11432

N30.0

ICD-10 Finland

Acute cystitis

2.0

44.9

588

3281

N94.1

ICD-10 Finland

Dyspareunia

4.4

44.8

115

271

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

43.9

651

3790

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

43.7

667

3920

J01DB01

ATC

cefalexin; oral

2.2

43.5

2234

19082

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

42.4

900

5865

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.8

42.2

1263

9092

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

40.4

454

2387

R51.80

ICD-10 Finland

Headache

2.0

40.2

570

3255

N02AX02

ATC

tramadol; systemic, rectal

1.8

39.8

934

6244

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.0

39.3

492

2688

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

39.1

587

3413

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.9

39.1

197

720

A02BC02

ATC

pantoprazole; systemic

1.7

38.0

1643

12942

UKC02

NOMESCO Finland

Cystoscopy

2.6

37.9

241

993

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

37.6

546

3137

E0000UV, ,

ATC

1.7

37.5

1208

8780

R52.9

ICD-10 Finland

Pain, unspecified

2.4

37.4

284

1270

A02BC05

ATC

esomeprazole; systemic

1.7

37.3

1001

6920

X90

ICPC

Genital herpes female

7.9

35.8

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

35.5

601

3619

N771, B977,

ICD-10 Finland

+∞

35.5

J01FA10

ATC

azithromycin; systemic

1.7

34.8

1735

14037

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

5.2

34.2

140

N70.0

ICD-10 Finland

Acute salpingitis and oophoritis

77.2

33.9

J01AA02

ATC

doxycycline; systemic

1.7

33.5

1915

15988

UJF32

NOMESCO Finland

Coloscopy

1.9

33.4

520

3043

D07AC01

ATC

betamethasone; topical

1.7

33.2

913

6302

H02AB06

ATC

prednisolone; systemic

1.6

32.4

1137

8345

J01FF01

ATC

clindamycin; systemic

1.8

32.4

673

4295

N03AX16

ATC

[U] pregabalin

1.9

32.2

531

3160

N06AX11

ATC

mirtazapine; oral

1.7

31.9

888

6137

U01

ICPC

Dysuria/painful urination

2.2

31.8

298

1453

R53

ICD-10 Finland

Malaise and fatigue

1.7

31.4

698

4534

D06

ICPC

Abdominal pain localized other

2.2

31.3

303

1495

XKD00

NOMESCO Finland

Uroflowmetry

3.2

31.2

126

405

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

31.1

344

1786

A10AE04

ATC

insulin glargine; parenteral

2.5

30.3

194

800

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

30.0

257

1207

M79.6

ICD-10 Finland

Pain in limb

1.6

29.9

1103

8145

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

4.7

29.2

148

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

29.1

367

1994

A02BC03

ATC

lansoprazole; oral

1.7

29.0

620

3972

R01AD09

ATC

mometasone; nasal

1.6

28.6

1355

10581

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

28.4

467

2768

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

28.0

1651

13536

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

27.7

855

6018

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

146.6

27.7

U02

ICPC

Urinary frequency/urgency

1.9

27.5

434

2536

C05AA08

ATC

fluocortolone; rectal, topical

2.0

27.4

313

1640

SPAT1262

SPAT

Handing over of treatment supplies

2.0

27.3

338

1823

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

27.2

356

1957

R42

ICD-10 Finland

Dizziness and giddiness

1.8

27.1

509

3134

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.7

26.9

727

4942

N05BA04

ATC

oxazepam; oral

1.7

26.6

694

4673

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

26.5

454

2719

N30

ICD-10 Finland

Cystitis

2.0

26.4

314

1669

X15

ICPC

Vaginal symptom/complaint other

2.3

26.0

206

935

N02BE01

ATC

paracetamol; systemic, rectal

1.9

25.9

2271

20387

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

25.8

553

3529

LCA06

NOMESCO Finland

Biopsy of endometrium

1.9

25.8

401

2329

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

25.7

892

6431

J01MA12

ATC

levofloxacin; systemic

1.9

25.7

353

1971

N06AB04

ATC

citalopram; systemic

1.7

25.4

545

3480

N05CF01

ATC

zopiclone; oral

1.6

25.3

683

4630

G01AF05

ATC

econazole; vaginal

2.0

25.1

284

1481

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

252.5

24.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

24.5

980

7280

T78.4

ICD-10 Finland

Allergy, unspecified

2.4

24.4

183

810

M01AE02

ATC

naproxen; oral, rectal

1.5

24.4

1568

12906

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

24.3

1420

11445

G44.2

ICD-10 Finland

Tension-type headache

1.8

24.2

452

2771

M79.1

ICD-10 Finland

Myalgia

1.8

24.0

450

2761

N71.9

ICD-10 Finland

Inflammatory disease of uterus, unspecified

6.3

24.0

R50.9

ICD-10 Finland

Fever, unspecified

1.9

23.9

362

2082

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

20.9

23.9

G04CA02

ATC

tamsulosin; oral

3.8

23.8

192

J01DA01

ATC

[U] cefalexin

1.5

23.8

1571

12974

M03BX02

ATC

tizanidine; oral

1.5

23.5

1627

13556

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.1

23.5

224

1096

D01

ICPC

Abdominal pain/cramps general

1.8

23.4

381

2240

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

23.3

362

2098

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.8

23.3

410

2468

X72

ICPC

Genital candidiasis female

3.5

22.9

230

R06.0

ICD-10 Finland

Dyspnoea

1.7

22.9

563

3714

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

22.8

579

3851

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

22.8

779

5565

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

22.5

279

1501

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

22.4

521

3384

AA1AD

NOMESCO Finland

CT of head and brain

1.7

22.4

450

2811

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

6.2

22.4

N75.0

ICD-10 Finland

Cyst of Bartholin gland

8.4

22.3

A07AA02

ATC

nystatin; oral

2.6

22.3

136

548

Z2221

NOMESCO Finland

Medical doctor

1.6

22.2

740

5248

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

22.2

206

997

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

22.1

392

2362

R03AC02

ATC

salbutamol; inhalant

1.5

21.9

1486

12240

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

21.8

399

2425

D06BB10

ATC

imiquimod; topical

2.4

21.8

152

651

N75.1

ICD-10 Finland

Abscess of Bartholin gland

8.1

21.8

A10AB05

ATC

insulin aspart; parenteral

2.3

21.7

166

742

R21

ICPC

Throat symptom/complaint

1.5

21.6

798

5785

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

21.6

527

3463

K59.0

ICD-10 Finland

Constipation

2.5

21.6

136

556

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

21.6

780

5629

L43.0

ICD-10 Finland

Hypertrophic lichen planus

8.8

21.5

N76

ICD-10 Finland

Other inflammation of vagina and vulva

3.7

21.5

187

R33

ICD-10 Finland

Retention of urine

3.1

21.5

291

E000006, ,

ATC

2.2

21.4

195

936

R05

ICD-10 Finland

Cough

1.6

21.2

539

3577

N76.4

ICD-10 Finland

Abscess of vulva

7.0

21.2

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.8

21.2

366

2187

R06AE07

ATC

cetirizine; oral

1.5

21.1

1277

10246

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

21.1

468

3000

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

21.0

341

1999

R01AD08

ATC

fluticasone; nasal

1.5

21.0

812

5938

N06AX16

ATC

venlafaxine; oral

1.7

21.0

442

2794

R01AD58

ATC

fluticasone, combinations; nasal

1.5

20.9

800

5840

H02AB04

ATC

methylprednisolone; systemic

1.8

20.8

336

1968

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

20.7

1027

7909

R39.1

ICD-10 Finland

Other difficulties with micturition

4.2

20.6

134

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.1

20.6

283

N06AX21

ATC

duloxetine; oral

1.8

20.4

325

1894

N03AX12

ATC

[U] gabapentin; oral

1.8

20.4

363

2187

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

20.4

194

948

R01AD12

ATC

fluticasone furoate; nasal

1.5

20.3

998

7663

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.7

20.3

109

412

M01AH05

ATC

etoricoxib; oral

1.5

20.2

1504

12523

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

20.0

252

1362

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

20.0

641

4490

L17

ICPC

Foot/toe symptom/complaint

1.5

19.7

685

4883

M25.5

ICD-10 Finland

Pain in joint

1.5

19.6

854

6384

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

19.5

190

936

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

19.5

756

5517

N95.0

ICD-10 Finland

Postmenopausal bleeding

2.1

19.4

203

1027

K30

ICD-10 Finland

Functional dyspepsia

1.8

19.4

317

1861

A02BA02

ATC

ranitidine; systemic

1.7

19.3

358

2180

K08.80

ICD-10 Finland

Toothache NOS

1.8

19.3

290

1659

D06BB04

ATC

podophyllotoxin; topical

2.0

19.3

205

1044

R06AX27

ATC

desloratadine; oral

1.5

19.2

908

6895

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

19.2

244

1322

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

5.3

19.2

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

18.8

449

2926

X14

ICPC

Vaginal discharge

2.5

18.7

123

513

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

18.5

401

2547

G01AF04

ATC

miconazole; vaginal

2.2

18.4

163

773

A10BK03

ATC

empagliflozin; oral

2.2

18.4

156

727

A04

ICPC

Weakness/tiredness general

1.7

18.4

414

2655

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

18.4

610

4294

M54.2

ICD-10 Finland

Cervicalgia

2.0

18.2

222

1186

H02AB07

ATC

prednisone; oral

1.8

18.1

295

1729

N01

ICPC

Headache

1.7

18.1

421

2723

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

18.1

206

1075

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

5.4

18.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

18.0

145

662

R11

ICD-10 Finland

Nausea and vomiting

1.9

17.9

242

1338

Z01.2

ICD-10 Finland

Dental examination

1.4

17.8

1295

10630

WX002

NOMESCO Finland

Sedation and analgesia

1.7

17.8

372

2340

N77.8*M35.2

ICD-10 Finland

Ulceration of vulva in Behçet's disease

+∞

17.7

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

17.7

253

1424

A02BC01

ATC

omeprazole; systemic

1.5

17.7

604

4273

N05CF02

ATC

zolpidem; oral

1.6

17.6

442

2912

M54.5

ICD-10 Finland

Low back pain

1.5

17.6

936

7246

R35

ICD-10 Finland

Polyuria

2.5

17.6

113

467

T90

ICPC

Diabetes non-insulin dependent

1.7

17.5

333

2040

N06AB10

ATC

escitalopram; oral

1.5

17.5

651

4690

M01AB05

ATC

diclofenac; systemic, rectal

1.4

17.5

1572

13390

XQ800

NOMESCO Finland

Prick test

1.8

17.4

259

1476

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.8

17.4

283

1658

L30.4

ICD-10 Finland

Erythema intertrigo

4.5

17.3

N06AB03

ATC

fluoxetine; oral

1.7

17.2

330

2026

A01AB09

ATC

miconazole; local oral

2.0

17.2

197

1030

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

17.2

188

967

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

17.2

297

1771

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

17.2

146

682

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

3.1

17.1

243

U07

ICPC

Urine symptom/complaint other

2.1

17.1

174

872

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

17.0

248

1404

J01MA06

ATC

norfloxacin; oral

1.7

16.9

318

1941

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

16.9

107

439

P06

ICPC

Sleep disturbance

1.7

16.9

327

2012

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

16.9

139

641

J05AB09

ATC

famciclovir; oral

6.1

16.9

L43

ICD-10 Finland

Lichen planus

4.3

16.7

102

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

16.5

279

1651

N05AH04

ATC

quetiapine; oral

1.6

16.5

477

3246

N03AE01

ATC

clonazepam; systemic

2.3

16.4

130

589

Z3231

NOMESCO Finland

Registered nurse

1.5

16.4

577

4098

D11

ICPC

Diarrhoea

1.6

16.4

375

2412

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

16.3

836

6402

S02

ICPC

Pruritus

2.4

16.3

114

490

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

16.3

226

1260

H01.0

ICD-10 Finland

Blepharitis

1.9

16.2

204

1102

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

16.1

123

549

A10BK01

ATC

dapagliflozin; oral

2.4

16.1

115

499

L01

ICPC

Neck symptom/complaint

1.6

16.0

450

3040

R51

ICD-10 Finland

Headache

1.9

16.0

195

1042

U71

ICPC

Cystitis/urinary infection other

1.9

16.0

208

1136

L02

ICPC

Back symptom/complaint

1.7

15.9

303

1856

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

15.8

302

1849

J01FA09

ATC

clarithromycin; systemic

1.4

15.8

809

6186

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

15.8

143

685

J01DA09

ATC

[U] cefadroxil

1.5

15.7

656

4823

N06AA09

ATC

amitriptyline; systemic

1.9

15.7

195

1048

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

15.7

278

1668

6146A

ICD-9 Finland

Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female

+∞

15.6

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

15.6

674

4990

R03DC03

ATC

montelukast; oral

1.6

15.6

462

3159

R07.0

ICD-10 Finland

Pain in throat

1.8

15.5

238

1368

J01MA01

ATC

ofloxacin; systemic

2.1

15.5

149

730

ZXE00

NOMESCO Finland

One hour or less

1.4

15.5

957

7567

A10BA02

ATC

metformin; oral

1.6

15.3

426

2868

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

15.3

899

7040

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

15.3

119

536

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

15.2

332

2106

ZXD05

NOMESCO Finland

Urgent procedure

1.4

15.2

765

5825

F43.0

ICD-10 Finland

Acute stress reaction

1.8

15.2

223

1265

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

15.2

983

7831

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

15.1

387

2556

N06AB06

ATC

sertraline; oral

1.6

15.1

343

2200

Z3226

NOMESCO Finland

Physiotherapist

1.6

15.0

385

2544

S29

ICPC

Skin symptom/complaint other

1.6

14.9

438

2984

N76.5

ICD-10 Finland

Ulceration of vagina

6.8

14.9

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

14.8

236

1372

U05

ICPC

Urination problems other

2.5

14.8

363

Z71.8

ICD-10 Finland

Other specified counselling

1.4

14.7

870

6810

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

14.7

249

1474

JAH01

NOMESCO Finland

Laparoscopy

2.2

14.7

128

604

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

14.7

397

2654

C03CA01

ATC

furosemide; systemic

1.6

14.6

332

2127

C07AA05

ATC

propranolol; systemic

1.5

14.6

580

4213

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

14.6

206

1155

A01

ICPC

Pain general/multiple sites

1.8

14.5

213

1207

T89

ICPC

Diabetes insulin dependent

2.3

14.5

105

458

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

14.5

1048

8485

G04BD11

ATC

fesoterodine; oral

3.3

14.5

166

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.6

14.5

319

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

14.4

242

1428

A10AE05

ATC

insulin detemir; parenteral

2.3

14.4

113

511

J01FA06

ATC

roxithromycin; oral

1.4

14.4

932

7406

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

14.4

273

1669

L03

ICPC

Low back symptom/complaint

1.4

14.4

729

5548

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

14.4

231

1347

H57.1

ICD-10 Finland

Ocular pain

2.2

14.3

119

551

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.9

14.3

110

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

14.3

298

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.9

14.2

191

1053

P01

ICPC

Feeling anxious/nervous/tense

1.5

14.2

496

3507

G04BD12

ATC

mirabegron; oral

1.9

14.1

180

977

N06AG02

ATC

moclobemide; oral

2.4

14.1

384

R07.3

ICD-10 Finland

Other chest pain

1.8

14.0

211

1205

N64.4

ICD-10 Finland

Mastodynia

2.1

14.0

133

649

J01

ICD-10 Finland

Acute sinusitis

1.9

14.0

191

1058

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

13.9

491

3477

SPAT1263

SPAT

Sampling

1.4

13.9

1061

8649

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

13.9

519

3718

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

13.9

174

937

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

13.8

250

1507

M54.8

ICD-10 Finland

Other dorsalgia

2.1

13.8

126

606

A99

ICPC

Disease/condition unspecnature/site

1.8

13.8

207

1182

M54

ICD-10 Finland

Dorsalgia

1.6

13.8

347

2279

X16

ICPC

Vulval symptom/complaint

2.8

13.7

258

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

5.3

13.7

G01AF01

ATC

metronidazole; vaginal

1.7

13.7

256

1557

E000001, ,

ATC

1.5

13.7

540

3911

N90.9

ICD-10 Finland

Noninflammatory disorder of vulva and perineum, unspecified

4.2

13.7

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

13.7

121

575

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

13.7

100

439

SPAT1310

SPAT

Counselling related to known health issue

1.4

13.6

783

6082

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

13.6

604

4477

B02AA02

ATC

tranexamic acid; systemic

1.5

13.6

467

3290

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.7

13.5

262

1609

A10AB04

ATC

insulin lispro; parenteral

2.5

13.4

350

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

13.4

133

661

R06.4

ICD-10 Finland

Hyperventilation

3.2

13.3

165

Z2446

NOMESCO Finland

Social worker

1.9

13.3

161

858

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

13.3

214

1248

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

13.3

694

5298

G47.3

ICD-10 Finland

Sleep apnoea

1.6

13.2

358

2390

R13

ICD-10 Finland

Dysphagia

2.0

13.2

136

684

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

13.2

440

3076

A60.9

ICD-10 Finland

Anogenital herpesviral infection, unspecified

9.7

13.2

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

13.2

241

1458

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

13.1

210

1222

D09

ICPC

Nausea

1.9

13.1

165

891

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

13.1

179

993

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

13.1

203

1171

A02BC04

ATC

rabeprazole; oral

1.8

13.0

213

1247

R74

ICPC

Upper respiratory infection acute

1.4

13.0

1050

8609

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

13.0

124

606

R52.2

ICD-10 Finland

Other chronic pain

2.4

13.0

398

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

13.0

626

4706

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

13.0

519

3766

H04AA01

ATC

glucagon; nasal, parenteral

2.5

12.9

320

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.6

12.9

352

2356

KCV04

NOMESCO Finland

Distension of bladder with fluid

4.9

12.8

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.5

12.8

309

J01CA04

ATC

amoxicillin; systemic

1.5

12.8

2187

20240

R10.0

ICD-10 Finland

Acute abdomen

2.4

12.8

364

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

12.8

111

524

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

12.7

270

1698

R60.0

ICD-10 Finland

Localized oedema

1.8

12.7

215

1271

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

12.7

428

2997

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

12.7

113

538

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

12.7

329

2174

A46

ICD-10 Finland

Erysipelas

1.8

12.7

195

1122

R4110

NOMESCO Finland

Physiotherapy

1.5

12.6

545

4012

6140A

ICD-9 Finland

Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Acute salpingitis and oophoritis[S-O-ITIS ACUTA]

+∞

12.5

61207

ICD-8 Finland

Acute salpingitis and oophoritis, suspecta

+∞

12.5

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

12.5

482

3471

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

12.5

190

1090

M02AA07

ATC

piroxicam; topical

1.4

12.5

676

5184

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

12.5

1953

17721

G03DB01

ATC

dydrogesterone; oral

1.5

12.4

440

3112

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

12.4

115

556

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

12.4

120

590

UJF92

NOMESCO Finland

Capsular endoscopy

2.9

12.4

210

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

12.4

100

458

A10AC01

ATC

insulin (human); parenteral

1.9

12.4

153

821

H29

ICPC

Ear symptom/complaint other

1.7

12.4

235

1435

XLA10, ,

NOMESCO Finland

2.0

12.4

140

729

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

12.4

203

1190

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

12.4

214

1274

A97

ICPC

No disease

1.5

12.3

422

2964

H92.0

ICD-10 Finland

Otalgia

1.8

12.3

185

1056

OAB50, ,

SPAT

2.2

12.2

101

467

N90.4

ICD-10 Finland

Leukoplakia of vulva

9.7

12.2

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.0

12.2

174

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

12.2

128

650

N05BA12

ATC

alprazolam; oral

1.7

12.1

225

1365

G04BD07

ATC

tolterodine; oral

2.4

12.1

360

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

12.1

2377

22468

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

12.1

542

4012

J01DC02

ATC

cefuroxime; systemic

1.9

12.1

150

806

C01CA24

ATC

epinephrine; parenteral

1.8

12.1

201

1183

A10AB01

ATC

insulin (human); parenteral

2.3

12.1

380

S18

ICPC

Laceration/cut

1.4

12.1

883

7109

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

12.0

615

4662

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

12.0

205

1215

S01

ICPC

Pain/tenderness of skin

2.2

12.0

105

497

A01AB04

ATC

amphotericin B; local oral

2.3

12.0

381

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.1

11.9

161

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

11.9

1869

16884

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

11.7

525

3885

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

3.6

11.6

103

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

11.6

393

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

11.6

194

1145

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

11.1

11.5

R06AE09

ATC

levocetirizine; oral

1.5

11.5

420

2986

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.7

11.5

225

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

11.4

417

2965

G04BD08

ATC

solifenacin; oral

2.1

11.4

102

487

H00.00

ICD-10 Finland

Hordeolum

2.0

11.4

131

686

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

11.4

140

750

D07AB08

ATC

desonide; topical

1.6

11.4

273

1769

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

11.4

272

1762

R12

ICD-10 Finland

Heartburn

1.7

11.4

192

1135

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

2.9

11.3

187

O99.80

ICD-10 Finland

The fear of childbirth

1.7

11.3

234

1462

S21

ICPC

Skin texture symptom/complaint

1.6

11.3

305

2033

L28

ICPC

Limited function/disability (L)

1.6

11.3

281

1838

L18

ICPC

Muscle pain

2.1

11.3

107

523

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

11.3

113

564

X23

ICPC

Fear sexually transm dis female

1.6

11.2

267

1728

SPAT1260

SPAT

Consultation of another employee

1.5

11.2

390

2746

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

11.2

314

2111

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

11.1

134

713

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

11.1

109

539

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

11.1

206

1249

A06AC51

ATC

ispaghula, combinations; oral

2.1

11.1

106

519

LDA10

NOMESCO Finland

Curettage of cervix uteri

1.9

11.1

149

822

R00.2

ICD-10 Finland

Palpitations

1.7

11.1

216

1329

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

11.1

193

1152

R03BA02

ATC

budesonide; inhalant

1.5

11.0

444

3216

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.1

11.0

109

542

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.9

11.0

174

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

11.0

859

6964

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

11.0

356

2470

N03AX09

ATC

lamotrigine; oral

1.8

11.0

154

862

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

4.8

11.0

B00.0

ICD-10 Finland

Eczema herpeticum

4.5

10.9

A07EA02

ATC

hydrocortisone; rectal

2.8

10.9

202

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

10.9

368

2573

EKA10

NOMESCO Finland

iopsy of buccal mucosa

2.8

10.9

191

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

10.9

227

1421

R05

ICPC

Cough

1.4

10.9

609

4680

P01AB02

ATC

tinidazole; oral, rectal

2.5

10.9

255

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.5

10.8

367

2568

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

10.8

194

1167

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

10.8

114

580

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

10.8

1220

10425

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

10.8

715

5648

ULC02

NOMESCO Finland

Hysteroscopy

1.9

10.7

143

787

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

10.7

233

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

10.7

193

1162

B37.08

ICD-10 Finland

Other candidal stomatitis

4.7

10.7

SPAT1312

SPAT

General health counselling

1.3

10.7

832

6732

G03CA04

ATC

estriol; systemic, vaginal

2.1

10.7

103

507

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.0

10.6

161

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.0

10.6

161

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

10.6

243

1558

R06AX22

ATC

ebastine; oral

1.4

10.6

473

3493

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.9

10.6

126

669

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

10.5

286

1910

D06BX01

ATC

metronidazole; topical

1.6

10.5

287

1919

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.9

10.4

168

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

10.4

182

1086

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

10.4

282

1880

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

10.4

218

1367

M01AH01

ATC

celecoxib; oral

1.5

10.4

328

2262

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

10.3

146

819

M35.2

ICD-10 Finland

Behçet disease

32.6

10.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

10.3

190

1151

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

10.3

346

2416

ZXA05

NOMESCO Finland

Left side

1.5

10.3

398

2859

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

10.3

189

1145

N05BA01

ATC

diazepam; systemic, rectal

1.6

10.2

254

1659

A06AD11

ATC

lactulose; oral

1.7

10.2

206

1278

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

10.2

395

L12

ICPC

Hand/finger symptom/complaint

1.5

10.2

394

2830

G43

ICD-10 Finland

Migraine

1.6

10.2

222

1406

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

10.2

118

621

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

10.1

212

1328

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.7

10.1

ZY010

NOMESCO Finland

Hospital outpatient

1.8

10.1

155

891

L04AX01

ATC

azathioprine; systemic

2.1

10.1

100

497

N03AG01

ATC

valproic acid; systemic, rectal

1.9

10.1

133

730

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

10.1

579

4462

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

10.1

111

574

N89.5

ICD-10 Finland

Stricture and atresia of vagina

11.3

10.0

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.2

10.0

359

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

10.0

370

2633

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

10.0

373

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

3.0

10.0

140

N77

ICD-10 Finland

Vulvovaginal ulceration and inflammation in diseases classified elsewhere

40.2

10.0

S06.0

ICD-10 Finland

Concussion

1.6

10.0

231

1485

J20

ICD-10 Finland

Acute bronchitis

1.6

10.0

234

1509

XKC03

NOMESCO Finland

Water cystometry

2.5

9.9

242

N06AX26

ATC

vortioxetine; oral

1.6

9.9

212

1335

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

9.9

480

SPAT1254

SPAT

Administration of medicine

1.5

9.9

304

2082

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

9.9

119

634

K60.1

ICD-10 Finland

Chronic anal fissure

2.4

9.9

267

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

9.9

148

846

ZXC10

NOMESCO Finland

Use of laser

2.7

9.8

185

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

9.8

348

2456

Z29

ICPC

Social problem NOS

2.4

9.8

274

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

3.6

9.8

D01AC03

ATC

econazole; topical

2.0

9.8

496

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

3.1

9.8

131

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

9.8

1790

16245

D07AC13

ATC

mometasone; topical

1.4

9.8

649

5114

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

9.8

456

N03AX11

ATC

topiramate; oral

2.1

9.7

430

R02

ICPC

Shortness of breath/dyspnoea

1.6

9.7

254

1680

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.7

1048

8856

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

9.7

169

1009

SPAT1324

SPAT

Screening procedure

0.7

9.6

384

5189

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

9.6

333

Z2445

NOMESCO Finland

Psychologist

1.9

9.6

115

612

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

9.6

419

N05AH03

ATC

olanzapine; systemic

1.8

9.6

148

854

L43.3

ICD-10 Finland

Subacute (active) lichen planus

11.4

9.6

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.4

9.6

436

3227

J01AA07

ATC

tetracycline; systemic

1.4

9.5

423

3114

UJH02

NOMESCO Finland

Anoscopy

2.1

9.5

393

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.8

9.5

160

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

9.5

387

2803

N89.9

ICD-10 Finland

Noninflammatory disorder of vagina, unspecified

4.6

9.5

RS221, ,

NOMESCO Finland

3.1

9.5

128

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

2.3

9.5

316

U29

ICPC

Urinary symptom/complaint other

2.4

9.5

254

N63

ICD-10 Finland

Unspecified lump in breast

1.6

9.5

221

1423

C07AB07

ATC

bisoprolol; oral

1.3

9.5

701

5613

N39.3

ICD-10 Finland

Stress incontinence

1.7

9.4

184

1132

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

9.4

272

1840

L15

ICPC

Knee symptom/complaint

1.4

9.4

508

3871

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

9.4

339

2401

62200

ICD-8 Finland

Infective diseases of uterus (except cervix), vagina and vulva, Endometritis acuta

+∞

9.4

X58

ICD-10 Finland

Exposure to other specified factors

1.5

9.4

300

2073

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

9.4

208

1323

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.6

9.3

196

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

9.3

499

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

9.3

603

4732

M01AC06

ATC

meloxicam; systemic, rectal

1.3

9.2

727

5868

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.0

9.2

459

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

9.2

148

863

N30.2

ICD-10 Finland

Other chronic cystitis

3.8

9.2

H10

ICD-10 Finland

Conjunctivitis

1.6

9.2

222

1440

D02

ICPC

Abdominal pain epigastric

1.7

9.2

160

954

N83.1

ICD-10 Finland

Corpus luteum cyst

2.5

9.2

215

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.5

9.2

239

1410

FHL

Laparoscopy

2.5

9.2

239

F29

ICPC

Eye symptom/complaint other

1.6

9.2

219

1418

R01AD11

ATC

triamcinolone; nasal

1.6

9.2

216

1394

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

9.2

433

3223

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.7

9.2

175

XQ802

NOMESCO Finland

Epicutan test

1.8

9.1

129

724

A10BJ06

ATC

semaglutide; parenteral

2.0

9.1

454

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

9.1

196

1236

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.1

9.1

400

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

9.1

468

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.1

9.1

387

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.1

9.1

434

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

9.1

140

807

B37.0

ICD-10 Finland

Candidal stomatitis

3.5

9.1

R30.9

ICD-10 Finland

Painful micturition, unspecified

3.8

9.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

9.1

415

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.1

9.0

382

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.8

9.0

154

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.0

9.0

491

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.6

9.0

200

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.9

8.9

109

584

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

8.9

177

1096

TKD00

NOMESCO Finland

Dilatation of urethra

4.3

8.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

8.8

125

702

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.8

584

4589

A07AA09

ATC

vancomycin; oral

3.6

8.8

L08

ICPC

Shoulder symptom/complaint

1.4

8.8

426

3184

P25

ICPC

Phase of life problem adult

1.7

8.7

152

907

S04

ICPC

Lump/swelling localized

1.5

8.7

255

1729

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.7

692

5586

H01

ICPC

Ear pain/earache

1.5

8.7

324

2307

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.6

8.7

180

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

8.7

192

1220

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

8.7

191

1213

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

8.7

172

1064

L50.8

ICD-10 Finland

Other urticaria

2.3

8.7

265

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

8.6

186

1174

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

8.6

273

1881

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.9

8.6

110

598

A03FA02

ATC

cisapride; oral, rectal

1.8

8.6

124

700

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

8.6

113

620

ZXA10

NOMESCO Finland

Bilateral

1.4

8.6

339

2440

G50.1

ICD-10 Finland

Atypical facial pain

2.6

8.6

181

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

8.6

314

2228

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.5

8.6

217

N01BB02

ATC

lidocaine; parenteral

3.6

8.6

R03BA05

ATC

fluticasone; inhalant

1.4

8.5

431

3242

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

2.0

8.5

466

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

8.5

578

4558

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.0

8.5

412

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

8.5

104

559

J01AA04

ATC

lymecycline; systemic

1.4

8.5

377

2775

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

8.5

1013

8631

D07AA02

ATC

hydrocortisone; topical

1.4

8.4

362

2646

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.7

8.4

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

8.4

184

1166

LFF00

NOMESCO Finland

Marsupialisation of Bartholin gland

90.4

8.4

N17

ICPC

Vertigo/dizziness

1.5

8.4

246

1670

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

8.3

142

844

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

8.3

296

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

8.3

197

1275

X01

ICPC

Genital pain female

2.6

8.3

179

S00.0

ICD-10 Finland

Superficial injury of scalp

2.6

8.3

179

R51.81

ICD-10 Finland

Facial pain NOS

2.2

8.2

290

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

3.5

8.2

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.1

8.2

369

SPAT1301

SPAT

No procedures

1.3

8.2

665

5374

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.2

8.2

297

S06

ICPC

Rash localized

1.8

8.2

116

652

TLE00

NOMESCO Finland

Dilatation of vagina

14.5

8.2

D03

ICPC

Heartburn

2.0

8.2

445

A10BJ02

ATC

liraglutide; parenteral

2.3

8.2

272

WX892

NOMESCO Finland

Monitored bed care

1.8

8.2

109

602

S71

ICPC

Herpes simplex

3.0

8.2

113

K13.29

ICD-10 Finland

Indefinite leukoplakia

3.9

8.1

N87.0

ICD-10 Finland

Mild cervical dysplasia

1.9

8.1

531

G03HB01

ATC

cyproterone and estrogen; oral

1.4

8.1

399

2987

H00.1

ICD-10 Finland

Chalazion

1.9

8.1

482

N70.9

ICD-10 Finland

Salpingitis and oophoritis, unspecified

33.4

8.1

L13

ICPC

Hip symptom/complaint

1.4

8.1

330

2391

A10AE06

ATC

insulin degludec; parenteral

2.1

8.1

352

TLC02

NOMESCO Finland

Simple extraction of IUD

1.7

8.1

148

897

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.9

8.1

130

N87.1

ICD-10 Finland

Moderate cervical dysplasia

2.0

8.0

448

A07EC02

ATC

mesalazine; oral, rectal

1.8

8.0

115

649

M79.7

ICD-10 Finland

Fibromyalgia

1.9

8.0

104

569

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

8.0

346

P02

ICPC

Acute stress reaction

1.6

8.0

192

1244

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.4

8.0

224

R32

ICD-10 Finland

Unspecified urinary incontinence

2.4

8.0

224

L72.1

ICD-10 Finland

Trichilemmal cyst

1.7

8.0

133

784

K60.0

ICD-10 Finland

Acute anal fissure

2.9

8.0

125

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

8.0

175

1110

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.3

8.0

243

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

8.0

174

1103

P03

ICPC

Feeling depressed

1.4

8.0

334

2431

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

8.0

130

763

N02BF02

ATC

pregabalin; oral

1.8

8.0

124

718

K03.66

ICD-10 Finland

Tooth plaque

1.7

7.9

156

963

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

7.9

763

6309

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

7.9

248

1706

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.3

7.9

251

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.9

7.9

494

A04AA01

ATC

ondansetron; systemic, rectal

1.7

7.9

158

981

UJD02

NOMESCO Finland

Gastroscopy

2.0

7.8

383

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.8

7.8

112

632

G03CC04

ATC

estrone; systemic

2.5

7.8

202

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.7

7.8

155

P76

ICPC

Depressive disorder

1.5

7.8

209

1390

L04

ICPC

Chest symptom/complaint

1.7

7.8

140

844

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.7

7.8

141

852

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

7.8

707

5800

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

7.8

223

1506

M01AX01

ATC

nabumetone; oral

2.1

7.8

344

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

7.7

179

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

7.7

135

807

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.2

7.7

272

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

7.7

272

SDA03

NOMESCO Finland

Periodontal treatment

1.3

7.7

1027

8834

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

7.7

179

1151

L60.0

ICD-10 Finland

Ingrowing nail

1.8

7.7

106

591

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.8

7.7

114

650

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

7.7

555

4407

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

7.7

111

628

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

7.7

552

4380

N94.2

ICD-10 Finland

Vaginismus

6.4

7.7

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.9

7.7

117

N05BB01

ATC

hydroxyzine; systemic

1.7

7.7

151

932

F01

ICPC

Eye pain

2.0

7.7

393

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

7.7

138

832

Z70.8

ICD-10 Finland

Other sex counselling

3.4

7.7

RD210, ,

NOMESCO Finland

2.5

7.7

198

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

7.7

888

7511

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.0

7.7

428

A07EA06

ATC

budesonide; oral, local oral

2.0

7.7

442

SPAT1283

SPAT

Restricted health certificate

1.3

7.7

628

5079

R2110

NOMESCO Finland

Giving the first information

1.6

7.7

185

1202

A10BH01

ATC

sitagliptin; oral

1.8

7.6

111

630

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.1

7.6

360

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

7.6

464

LEE96

NOMESCO Finland

Other repair of vagina

18.4

7.6

J01XE01

ATC

nitrofurantoin; oral

2.4

7.6

205

N80.0

ICD-10 Finland

Endometriosis of uterus

2.1

7.6

347

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

7.6

166

1053

Z00.0

ICD-10 Finland

General medical examination

1.4

7.5

406

3083

O98.3

ICD-10 Finland

Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium

10.0

7.5

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

7.5

466

TKC22

NOMESCO Finland

Catheterisation instruction

3.8

7.5

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.4

7.5

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.4

7.5

194

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.2

7.5

263

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

7.5

191

1257

N06AB08

ATC

fluvoxamine; oral

2.2

7.5

257

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.6

7.5

183

1193

L09

ICPC

Arm symptom/complaint

1.8

7.4

118

687

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

7.4

959

8212

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

7.4

197

1308

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

7.4

324

M01AX17

ATC

nimesulide; oral

1.4

7.4

372

2795

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.7

7.4

128

765

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.9

7.4

520

N81.5

ICD-10 Finland

Vaginal enterocele

2.7

7.3

137

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.7

7.3

144

889

M48.0

ICD-10 Finland

Spinal stenosis

1.6

7.3

147

913

A10BG03

ATC

pioglitazone; oral

3.1

7.3

A92

ICPC

Allergy/allergic reaction NOS

1.8

7.3

543

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

7.3

128

767

C07AB02

ATC

metoprolol; systemic

1.5

7.3

262

1852

6150A

ICD-9 Finland

Inflammatory diseases of uterus, except cervix, Acute[ENDOMETRITIS, ENDOMYOMETRITIS ET PERIMETRITIS ACUTA]

+∞

7.3

N77.1*B80

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in pinworm infection

+∞

7.3

N75.8

ICD-10 Finland

Other diseases of Bartholin gland

10.9

7.3

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

7.3

117

684

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

7.3

319

M02AA10

ATC

ketoprofen; topical

1.4

7.3

287

2065

L04AX03

ATC

methotrexate; systemic

1.5

7.3

204

1371

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

4.2

7.3

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

7.3

141

868

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.3

7.3

241

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.3

7.2

216

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.2

7.2

248

G43.3

ICD-10 Finland

Complicated migraine

2.1

7.2

334

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

7.2

524

N81.6

ICD-10 Finland

Rectocele

1.6

7.2

146

910

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

7.2

103

583

SPAT1240

SPAT

Therapeutic discussion

1.4

7.2

337

2502

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

7.2

126

756

L30

ICD-10 Finland

Other dermatitis

2.1

7.1

308

G01AF08

ATC

tioconazole; vaginal

2.2

7.1

249

SPAT1375

SPAT

Structural ultrasound screening, weeks 18+0-21+6

2.3

7.1

237

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.0

7.1

405

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

7.1

100

563

N05BE01

ATC

buspirone; oral

2.2

7.1

276

R31

ICD-10 Finland

Unspecified haematuria

1.8

7.1

527

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

1.8

7.0

103

586

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.8

7.0

542

G03DA02

ATC

medroxyprogesterone; systemic

1.6

7.0

179

1177

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

7.0

1848

17127

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

7.0

154

979

EMB10

NOMESCO Finland

Tonsillectomy

1.5

7.0

197

1326

N05AA02

ATC

levomepromazine; systemic

2.0

7.0

352

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.4

7.0

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

7.0

214

1467

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

7.0

596

4841

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

6.9

182

1205

C10AA07

ATC

rosuvastatin; oral

1.3

6.9

459

3595

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.8

6.9

508

K58

ICD-10 Finland

Irritable bowel syndrome

1.9

6.9

415

A03

ICPC

Fever

1.3

6.9

476

3749

M01AH02

ATC

rofecoxib; oral

1.5

6.9

184

1222

D01AC02

ATC

miconazole; topical

1.7

6.9

113

664

ZXA00

NOMESCO Finland

Right side

1.4

6.9

410

3159

S01XA18

ATC

ciclosporin; ophthalmic

3.7

6.9

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

6.9

227

1577

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

6.9

180

1191

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.1

6.9

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.0

6.9

340

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

6.9

195

1314

K05.18

ICD-10 Finland

Chronic gingivitis

1.6

6.9

175

1152

N64.5

ICD-10 Finland

Other signs and symptoms in breast

1.9

6.9

424

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

6.9

320

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

6.9

253

1798

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

6.8

141

882

X99

ICPC

Genital disease female other

3.5

6.8

ECA20

NOMESCO Finland

Biopsy of gingiva

3.4

6.8

N81.1

ICD-10 Finland

Cystocele

1.7

6.8

130

797

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

6.8

224

1556

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.1

6.8

294

Z00.8

ICD-10 Finland

Other general examinations

1.6

6.8

171

1122

R41.0

ICD-10 Finland

Disorientation, unspecified

2.8

6.8

120

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

6.8

332

2481

ZX120

NOMESCO Finland

Intravenous

1.6

6.8

166

1083

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.7

6.8

126

M54.1

ICD-10 Finland

Radiculopathy

1.9

6.8

398

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.9

6.8

398

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

6.8

151

964

X29

ICPC

Genital sympt/compl female other

2.3

6.8

223

N90.0

ICD-10 Finland

Mild vulvar dysplasia

5.7

6.8

A10AA01, ,

ATC

2.1

6.7

275

JF2BD

NOMESCO Finland

Extensive colon CT

4.3

6.7

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

6.7

187

1255

C10AA01

ATC

simvastatin; oral

1.3

6.7

419

3253

RS121, ,

NOMESCO Finland

3.9

6.7

D01BA02

ATC

terbinafine; oral

1.4

6.7

396

3049

N06AX05

ATC

trazodone; oral

2.1

6.7

316

A10AD01

ATC

insulin (human); parenteral

2.6

6.7

144

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.6

6.7

151

966

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

6.7

529

L04AD01

ATC

ciclosporin; systemic

2.5

6.7

162

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.7

6.7

107

626

H93.1

ICD-10 Finland

Tinnitus

1.7

6.6

125

764

M54.3

ICD-10 Finland

Sciatica

1.7

6.6

116

695

S80.0

ICD-10 Finland

Contusion of knee

1.5

6.6

183

1226

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

6.6

225

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

6.6

723

6051

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

6.6

311

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

6.6

561

SPAT1255

SPAT

Intravenous administration of medicine

1.7

6.6

115

689

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

6.6

125

766

B02

ICD-10 Finland

Zoster [herpes zoster]

1.8

6.6

488

G04AC01, ,

ATC

2.0

6.6

353

Z72.2

ICD-10 Finland

Drug use

3.5

6.6

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

6.6

188

1270

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.6

121

736

R15

ICD-10 Finland

Faecal incontinence

2.2

6.5

252

SPAT1167

SPAT

Insertion of urinary catheter

3.0

6.5

K07.60

ICD-10 Finland

Snapping jaw

1.6

6.5

164

1076

R30.1

ICD-10 Finland

Vesical tenesmus

2.4

6.5

170

SBA00

NOMESCO Finland

Microbiological examinations

2.1

6.5

259

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

6.5

122

745

R29

ICPC

Respiratory symptom/complaint other

1.6

6.5

145

925

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.8

6.5

112

N97.9

ICD-10 Finland

Female infertility, unspecified

1.5

6.5

208

1439

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

6.5

169

1119

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.4

6.4

171

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

6.4

123

755

SAA04

NOMESCO Finland

Special examination of mouth

1.7

6.4

123

755

A10AA02, ,

ATC

2.1

6.4

287

ZXC50

NOMESCO Finland

Cryotherapy

2.5

6.4

159

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.5

6.4

R55

ICD-10 Finland

Syncope and collapse

1.6

6.4

165

1088

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.7

6.4

112

671

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

6.4

398

X57

ICD-10 Finland

Unspecified privation

2.3

6.4

190

R03BA01

ATC

beclometasone; inhalant

1.4

6.4

288

2121

B07.9

ICD-10 Finland

Verruca simplex

1.8

6.4

485

SPAT1373

SPAT

Combined screening in early pregnancy

1.9

6.4

413

N06AA10

ATC

nortriptyline; systemic

2.2

6.4

229

N94.9

ICD-10 Finland

Unspecified condition associated with female genital organs and menstrual cycle

4.1

6.4

L20.0

ICD-10 Finland

Besnier prurigo

1.4

6.3

234

1663

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

6.3

244

1749

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.4

6.3

259

1878

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.9

6.3

387

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

1.7

6.3

577

R09

ICPC

Sinus symptom/complaint

1.4

6.3

253

1828

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.8

6.3

525

C05AA01

ATC

hydrocortisone; rectal, topical

1.9

6.3

416

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

6.3

293

2173

A10BB12

ATC

glimepiride; oral

2.2

6.2

244

-60

ICPC

Result test/procedure

1.7

6.2

115

700

G01AF02

ATC

clotrimazole; vaginal

1.8

6.2

504

D01AA02

ATC

natamycin; topical

2.3

6.2

199

C09CA06

ATC

candesartan; oral

1.3

6.2

426

3351

L50.9

ICD-10 Finland

Urticaria, unspecified

1.7

6.2

105

624

L05

ICPC

Flank/axilla symptom/complaint

1.7

6.2

117

716

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

6.2

166

1105

SPAT1104

SPAT

Monitoring of emergency patient

1.7

6.2

114

693

R01AD01

ATC

beclometasone; nasal

1.4

6.2

348

2658

DFF59

NOMESCO Finland

Other assessment of balance

3.1

6.2

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

6.2

147

953

B00

ICD-10 Finland

Herpesviral [herpes simplex] infections

5.0

6.2

N80.8

ICD-10 Finland

Other endometriosis

5.3

6.1

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

6.1

122

757

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.3

6.1

A01AB10

ATC

natamycin; local oral

1.9

6.1

369

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

6.1

492

L50.3

ICD-10 Finland

Dermatographic urticaria

2.1

6.1

266

N89.8

ICD-10 Finland

Other specified noninflammatory disorders of vagina

2.8

6.1

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

6.1

116

712

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.7

6.1

100

590

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.7

6.1

116

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

6.1

449

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

6.0

1336

12043

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.3

6.0

386

3006

A10BG02

ATC

rosiglitazone; oral

3.6

6.0

A10BJ05

ATC

dulaglutide; parenteral

2.6

6.0

134

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

6.0

197

1368

SFA20

NOMESCO Finland

Two-surface restoration

1.2

6.0

1489

13576

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026389) Candida sp identified in Specimen by Organism specific culture

158

318

5.23

74.61

1.7

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1929

14743

2.19

65.71

6.2

3.8

330.17

1943.37

e6/l

2.14

147

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

865

5143

2.02

57.40

2.7

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1934

15218

2.06

54.86

5.8

3.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

923

5760

1.93

52.17

2.9

2.1

—

(3018095) Leukocytes [#/volume] in Urine

1043

6796

1.89

51.52

4.5

3.1

175.70

77.30

e6/l

0.72

721

4284

(40768804) Tissue Pathology biopsy report

1292

9010

1.86

51.50

2.3

1.9

—

(3002582) Erythrocytes [#/volume] in Urine

849

5272

1.91

47.84

3.9

2.7

93.65

88.48

e6/l

0.04

652

3870

(36304419) Bacteria [Presence] in Urine

791

4863

1.90

45.53

3.5

2.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

540

2921

2.07

44.92

2.1

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1939

15706

1.92

44.70

4.8

3.7

10.26

10.02

mm/h

0.41

1817

14711

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1297

9375

1.76

43.06

5.6

5.1

9.23

9.72

umol/l

1.74

1210

8816

(3030467) Casts [#/volume] in Urine by Automated count

774

4821

1.86

42.19

3.7

2.6

0.32

0.34

e6/l

0.05

580

3509

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

876

5674

1.82

42.04

2.9

2.2

54.12

56.58

u/l

1.20

817

5237

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1850

14895

1.84

41.75

8.0

6.4

71.12

72.45

u/l

1.03

1741

14053

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

642

3791

1.92

41.13

2.3

1.8

—

(3026008) Bacteria identified in Urine by Culture

960

6433

1.78

40.82

3.5

2.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

928

6169

1.78

40.47

1.4

1.3

1.60

1.58

u/ml

0.01

245

1757

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

9.55

39.82

1.2

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1022

7050

1.74

38.75

2.0

1.8

101.08

99.01

pmol/l

0.62

555

3677

(3013115) Eosinophils [#/volume] in Blood

1442

10958

1.71

38.14

7.4

5.8

0.18

e9/l

0.31

1286

9838

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1068

7498

1.72

37.72

5.6

4.7

1.22

mmol/l

0.39

966

6889

(40760892) CBC W Ordered Manual Differential panel - Blood

1323

9851

1.70

37.50

7.7

5.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1552

12102

1.70

36.63

9.8

8.1

3.98

3.93

e9/l

0.42

1366

10690

(40768797) Stomach Pathology biopsy report

472

2603

1.99

36.48

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

565

3313

1.90

36.42

2.5

2.3

88.98

97.03

ug/g

0.39

447

2603

(3007853) Bacteria identified in Skin by Aerobe culture

416

2194

2.07

36.39

2.0

1.6

—

(3006315) Basophils [#/volume] in Blood

1391

10547

1.69

36.39

7.2

5.5

0.04

e9/l

1.09

1221

9297

(3000850) Epithelial cells [#/volume] in Urine

610

3672

1.86

36.20

3.1

2.3

11.38

9.28

e6/l

0.32

552

3238

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

245

4.16

36.14

1.2

1.1

—

(3001604) Monocytes [#/volume] in Blood

1387

10531

1.68

35.90

7.2

5.5

0.53

0.52

e9/l

0.78

1219

9303

(3019069) Monocytes/100 leukocytes in Blood

1317

9895

1.67

35.24

7.6

5.8

7.75

7.89

0.97

1223

9308

(3006504) Eosinophils/100 leukocytes in Blood

1310

9841

1.67

34.97

7.3

5.5

2.70

2.75

0.36

1212

9230

(3007164) IgA [Mass/volume] in Serum or Plasma

783

5142

1.75

34.45

1.5

1.4

2.03

2.09

g/l

0.61

477

3241

(3018010) Neutrophils/100 leukocytes in Blood

1345

10206

1.66

34.26

7.0

5.4

56.11

56.44

0.51

1250

9617

(3019198) Lymphocytes [#/volume] in Blood

1422

10950

1.66

34.15

7.2

5.5

2.03

1.97

e9/l

0.59

1283

9916

(3022096) Basophils/100 leukocytes in Blood

1263

9439

1.66

34.08

7.3

5.6

0.66

0.68

0.51

1157

8807

(3002030) Lymphocytes/100 leukocytes in Blood

1355

10334

1.65

33.56

7.3

5.5

30.17

29.68

1.00

1261

9750

(3021601) Nitrite [Presence] in Urine by Test strip

1421

11006

1.64

32.79

6.3

4.4

0.00

estimate

0.41

277

2202

(3009261) Glucose [Presence] in Urine by Test strip

1427

11083

1.64

32.40

4.7

3.2

0.01

0.00

estimate

0.29

272

2179

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2436

22122

2.59

32.29

15.9

10.0

17.50

18.74

mg/l

1.32

1999

16841

(3037522) Nuclear Ab [Titer] in Serum

550

3315

1.84

32.03

1.5

1.4

497.09

597.76

titre

0.61

103

697

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

451

2577

1.91

30.97

3.3

2.5

4.84

5.01

e6/l

0.10

235

1256

(3035350) Ketones [Presence] in Urine by Test strip

1409

10980

1.62

30.96

4.7

3.2

0.00

estimate

1.15

286

2268

(3015736) pH of Urine

1185

8871

1.62

30.61

4.1

3.0

6.07

5.97

0.64

145

838

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1532

12208

1.62

30.51

3.4

2.9

70.48

64.30

ug/l

0.87

1439

11519

(3026782) Osmolality of Urine

557

3431

1.79

29.96

3.7

2.5

496.37

525.61

mosm/kgh2o

2.38

489

2919

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1131

8402

1.61

29.94

6.5

5.3

1.22

mmol/l

0.18

961

7123

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

830

5725

1.66

29.53

3.5

2.6

20.03

33.00

ng/l

0.66

364

2605

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

984

7097

1.62

29.22

1.7

1.5

—

(3000494) Fungus identified in Specimen by Culture

399

2231

1.93

29.11

1.7

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

474

2803

1.85

29.07

2.9

2.3

0.98

1.33

e6/l

0.90

251

1475

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2245

19917

1.93

28.92

12.1

8.7

92.73

91.41

ml/min/173m2

2.25

1855

16110

(3013826) Glucose [Moles/volume] in Serum or Plasma

1375

10809

1.58

27.90

4.7

3.8

6.57

6.27

mmol/l

3.70

1252

9670

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2148

18885

1.79

27.28

5.2

4.3

14.38

pmol/l

0.02

1995

17612

(46235355) HIV 1 and 2 tests - Meaningful Use set

1039

7702

1.58

26.88

2.4

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1186

9103

1.56

26.08

2.6

2.2

77.30

74.92

nmol/l

2.18

1091

8461

(3025130) Human papilloma virus identified in Specimen

152

604

2.61

25.59

1.6

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

913

6630

1.58

25.45

2.5

1.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

694

4722

1.64

25.33

2.2

2.0

105.28

142.99

u/l

1.64

651

4480

(3024561) Albumin [Mass/volume] in Serum or Plasma

997

7398

1.56

25.24

5.0

4.0

36.81

36.68

g/l

0.38

933

6890

(3021960) Folate [Moles/volume] in Serum or Plasma

575

3776

1.67

23.92

1.6

1.4

21.28

21.39

nmol/l

0.06

507

3338

(3023103) Potassium [Moles/volume] in Serum or Plasma

2327

21170

1.94

23.79

14.7

10.1

3.89

3.90

mmol/l

0.92

2262

20483

(3019550) Sodium [Moles/volume] in Serum or Plasma

2322

21116

1.93

23.68

14.4

10.0

139.44

139.56

mmol/l

1.85

2264

20489

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

692

4809

1.60

22.77

1.9

1.8

0.62

0.88

mg/l

6.80

491

3540

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2331

21277

1.92

22.72

6.3

5.0

1.71

1.99

mu/l

1.46

2203

20105

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

702

4920

1.58

22.18

2.5

1.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2466

23011

2.38

22.11

11.3

8.3

23.28

23.32

u/l

0.05

2397

22283

(3023368) Bacteria identified in Blood by Culture

554

3675

1.64

21.93

4.8

3.6

—

(3013512) EKG study

636

4374

1.60

21.70

3.6

2.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.28

21.46

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

600

4101

1.60

20.90

1.3

9.07

9.92

u/ml

0.10

219

1713

(3009508) Creatinine [Moles/volume] in Urine

688

4863

1.56

20.72

4.3

3.1

7.32

7.22

mmol/l

0.18

593

4258

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

221

1127

2.05

20.71

2.1

1.6

—

(3042936) Bacteria identified in Isolate by Culture

378

2299

1.75

20.56

2.2

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

164

747

2.28

20.47

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1755

15072

1.51

20.23

3.5

2.6

34.43

32.71

u/l

0.44

1670

14357

(3022948) Iron [Moles/volume] in Serum or Plasma

434

2755

1.69

20.19

2.5

2.2

14.26

14.02

umol/l

0.28

413

2575

(3019309) Folate [Moles/volume] in Red Blood Cells

433

2748

1.69

20.16

1.8

1.7

1161.30

1203.12

nmol/l

0.45

343

2113

(3036481) Cortisol [Moles/volume] in Serum or Plasma

348

2079

1.78

20.11

2.1

2.0

375.56

378.47

nmol/l

0.11

319

1910

(3017143) Hepatitis C virus Ab [Presence] in Serum

525

3508

1.62

19.97

1.8

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

617

4287

1.58

19.91

1.3

32.89

26.59

iu/ml

0.45

189

1364

(3004789) Transferrin [Mass/volume] in Serum or Plasma

392

2434

1.72

19.76

2.5

2.2

2.45

2.49

g/l

0.61

359

2259

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2013

17850

1.57

19.57

5.7

4.2

38.97

37.51

mmol/mol

7.50

1896

16799

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

294

1689

1.84

19.32

2.1

1.8

—

(3019225) pH of Specimen

278

1579

1.85

18.93

3.5

3.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2429

22709

2.05

18.72

15.5

10.7

66.35

66.25

umol/l

0.08

2429

22700

(3033658) Prothrombin time (PT) actual/Normal

644

4573

1.54

18.70

4.3

3.2

98.08

97.61

0.20

630

4426

(3013139) Helicobacter pylori Ag [Presence] in Stool

271

1538

1.85

18.49

1.2

—

(40768443) Skin Pathology biopsy report

169

813

2.15

18.45

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

356

2192

1.72

18.42

2.6

2.3

23.34

23.00

0.18

312

1890

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2094

18814

1.58

18.40

4.3

3.8

—

(3018418) pH of Serum or Plasma

696

5044

1.52

18.33

4.2

3.4

7.40

0.66

129

982

(3022217) INR in Platelet poor plasma by Coagulation assay

880

6692

1.48

18.29

10.6

8.9

1.09

1.10

inr

0.25

297

2178

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

890

6799

1.47

18.01

3.4

2.8

28.11

28.63

u/l

0.17

833

6491

(3015377) Calcium [Moles/volume] in Serum or Plasma

826

6220

1.48

17.97

2.9

3.0

2.35

mmol/l

0.75

720

5638

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

335

2049

1.73

17.72

3.7

2.4

5.10

5.73

umol/l

0.43

271

1721

(3022145) Colonoscopy Study observation

333

2035

1.73

17.67

1.4

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

390

2489

1.67

17.61

4.0

3.2

0.82

mmol/l

0.75

365

2341

(3005322) IgE [Units/volume] in Serum or Plasma

295

1745

1.78

17.53

1.4

1.3

208.88

200.64

u/ml

0.05

274

1621

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

332

2049

1.71

16.97

3.8

3.4

32.91

33.15

0.15

254

1514

(3003327) Ova and parasites identified in Stool by Light microscopy

175

883

2.05

16.85

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

677

4951

1.50

16.83

4.3

3.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

210

1133

1.93

16.72

2.0

1.8

1.27

1.39

g/l

0.73

187

1051

(3012516) Albumin [Mass/volume] in Urine

559

3936

1.54

16.61

4.0

3.2

712.68

373.12

mg/l

0.65

372

2401

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

877

6761

1.45

16.60

2.1

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

691

5111

1.48

16.13

2.4

2.1

2.81

2.77

mg/l

0.19

573

4392

(3005719) IgG [Mass/volume] in Serum or Plasma

253

1473

1.79

15.82

3.0

2.7

10.12

10.47

g/l

0.86

228

1356

(3015171) Extractable nuclear Ab [Units/volume] in Serum

192

1026

1.94

15.72

1.2

1.3

0.21

1.32

u/ml

2.04

(3020682) Albumin/Creatinine [Ratio] in Urine

573

4107

1.51

15.53

4.9

3.8

7.95

9.57

mg/mmol

0.44

369

2540

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1270

10542

1.40

15.52

2.9

2.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1064

8585

1.41

15.28

5.0

3.2

—

(40758558) Short blood count panel - Blood

691

5176

1.46

14.92

7.7

6.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

285

1749

1.71

14.80

2.7

2.1

29.99

35.80

u/l

1.68

248

1477

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

374

2467

1.60

14.64

2.9

2.1

6416.89

6610.37

u/l

0.03

153

1047

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

149

753

2.04

14.30

4.0

3.1

5.13

5.14

kpa

0.08

139

728

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

144

719

2.06

14.28

3.9

3.1

1.30

1.53

mmol/l

0.28

100

527

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

523

3743

1.50

14.13

1.7

1.6

35965358.36

42069610.05

pmol/l

0.10

456

3209

(3041096) Erythrocytes [Presence] in Urine by Automated

814

6336

1.41

14.09

4.2

2.8

—

(3009343) pH of Capillary blood

147

747

2.03

13.90

3.9

3.1

7.42

7.41

0.69

103

(3000570) Elastase.pancreatic [Mass/mass] in Stool

100

438

2.33

13.73

1.5

1.3

327.40

318.78

ug/g

0.15

220

(3023511) Choriogonadotropin [Units/volume] in Urine

223

1306

1.77

13.65

1.5

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

591

4364

1.46

13.57

2.4

2.1

2942.46

3202.79

umol/l

0.08

507

3936

(3019832) Treponema pallidum Ab [Presence] in Serum

717

5490

1.42

13.51

1.8

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

291

1844

1.65

13.34

7.0

4.9

1.06

1.05

mmol/l

0.44

276

1716

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

456

3213

1.51

13.20

2.6

594.27

738.27

ng/l

0.66

357

2629

(40761511) CBC panel - Blood by Automated count

2468

23516

1.97

13.20

14.0

9.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

173

3.11

12.94

1.2

—

(3025941) Bacteria identified in Stool by Culture

233

1416

1.71

12.50

1.4

1.2

—

(36660697) Celiac disease serology panel - Serum

322

2166

1.56

11.46

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

349

2391

1.53

11.43

2.0

1.7

—

(3016879) Cocaine [Presence] in Urine

222

1376

1.67

11.06

4.1

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

355

2458

1.51

11.05

1.3

1.2

127.21

161.36

iu/ml

0.76

136

983

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

174

2.91

10.98

1.6

1.8

—

(3049717) Cytology report of Urine Cyto stain

296

2.44

10.94

2.0

2.2

—

(3007461) Platelets [#/volume] in Blood

2570

25027

3.26

10.83

22.9

15.2

267.11

268.25

e9/l

0.42

2537

24507

(3011412) CD3 cells [#/volume] in Blood

199

2.75

10.68

2.5

2.4

1.39

1.29

e9/l

0.31

175

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

135

734

1.89

10.54

1.7

2.1

0.22

0.23

g/l

0.61

129

690

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

359

2.27

10.46

1.4

1.2

—

(3024731) MCV [Entitic volume]

2570

25046

3.19

10.44

22.8

15.1

90.28

90.10

1.25

2553

24778

(3021447) Carbon dioxide [Partial pressure] in Venous blood

195

1186

1.70

10.43

4.9

3.4

5.91

5.80

kpa

0.74

187

1144

(3035941) MCH [Entitic mass]

2570

25048

3.18

10.40

22.8

15.1

30.04

29.97

1.47

2554

24778

(3026361) Erythrocytes [#/volume] in Blood

2570

25051

3.17

10.33

22.9

15.1

4.42

4.45

e12/l

2.57

2537

24492

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

230

1465

1.63

10.30

1.7

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

190

1152

1.70

10.28

4.4

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2566

24997

2.97

10.22

22.7

15.1

39.59

39.58

0.04

2489

23841

(3048929) Epstein Barr virus Ab [Presence] in Serum

169

996

1.75

10.13

1.3

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

332

2.30

10.13

6.5

5.1

382.22

601.24

iu/ml

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

138

766

1.85

10.11

3.7

2.4

0.23

0.26

e6/l

0.13

132

731

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

137

760

1.85

10.05

1.6

2.1

1.16

1.17

g/l

0.07

131

715

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

138

768

1.84

10.02

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

124

667

1.90

10.01

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

2569

25052

3.07

10.01

23.0

15.2

6.78

6.71

e9/l

0.65

2533

24479

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.06

9.96

1.2

1.1

96.48

96.06

0.03

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

123

663

1.90

9.87

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

418

3056

1.44

9.81

2.6

2.4

2.43

mmol/l

0.01

357

2662

(3000963) Hemoglobin [Mass/volume] in Blood

2569

25062

3.04

9.81

23.0

15.2

132.08

132.58

g/l

1.54

2553

24792

(42529406) Shigella sp [Presence] in Stool by Culture

124

673

1.88

9.75

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

198

2.66

9.69

1.5

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

796

6477

1.33

9.65

1.9

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

729

5857

1.34

9.64

5.5

3.5

0.00

estimate

0.26

276

2184

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

160

943

1.74

9.60

1.6

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

120

649

1.89

9.54

6.2

2.6

—

(3022313) Gas panel - Capillary blood

102

528

1.97

9.24

4.4

3.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

127

707

1.84

9.24

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

147

2.89

9.18

2.8

2.5

0.17

0.20

e9/l

0.52

123

(3000991) Gas panel - Venous blood

178

1094

1.67

9.17

7.5

7.0

—

(3002032) Base excess in Venous blood by calculation

188

1172

1.65

9.17

5.0

3.4

1.44

1.74

mmol/l

0.50

164

967

(3052851) Hemolysis interference index of Serum or Plasma

100

518

1.97

9.05

2.8

2.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2200

20688

1.41

8.99

4.2

3.5

4.73

4.82

mmol/l

4.19

2080

19637

(3028300) Cannabinoids [Presence] in Urine

230

1514

1.57

8.97

4.2

2.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

237

1574

1.56

8.89

4.3

227.92

239.73

u/l

0.52

227

1491

(3027008) Opiates [Presence] in Urine

229

1510

1.57

8.87

4.1

1.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

211

1366

1.59

8.84

1.1

80.00

147.66

titre

—

(3044889) 12 lead EKG panel

1458

12959

1.28

8.81

3.2

2.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

151

2.81

8.75

2.7

2.4

548.26

491.29

e6/l

0.38

124

(3000764) Benzodiazepines [Presence] in Urine

227

1499

1.56

8.73

4.2

2.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

238

1589

1.55

8.72

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

158

2.75

8.61

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2109

19731

1.36

8.58

3.7

3.2

1.20

1.18

mmol/l

0.97

1966

18621

(3027944) Amphetamines [Presence] in Urine

225

1490

1.56

8.55

3.4

2.0

—

(3017732) Neutrophils [#/volume] in Blood

229

1524

1.55

8.51

2.6

2.2

4.18

4.62

e9/l

0.73

180

1334

(3019150) Specific gravity of Urine by Refractometry

593

4695

1.34

8.50

5.1

3.5

1.01

1.02

kg/l

1.38

716

(3016650) Hepatitis A virus Ab [Presence] in Serum

345

2.15

8.47

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

322

2306

1.45

8.39

2.1

2.0

29.19

29.03

0.29

308

2224

(3021879) Hepatitis B virus core Ab [Presence] in Serum

319

2282

1.45

8.36

1.5

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

161

2.70

8.32

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

196

2.53

8.32

1.1

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2213

20894

1.40

8.27

4.5

3.8

2.79

2.87

mmol/l

5.48

2077

19733

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2185

20589

1.38

8.24

4.1

3.4

1.55

1.56

mmol/l

0.92

2051

19495

(3024354) Oxygen [Partial pressure] in Venous blood

158

974

1.66

8.07

4.6

2.8

4.42

4.63

kpa

0.72

151

937

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

265

1843

1.49

8.01

3.1

3.4

4.50

4.52

pmol/l

0.19

234

1656

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

373

2768

1.41

7.97

3.3

2.9

62.15

369.64

ng/l

3.07

176

1564

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

159

2.67

7.97

2.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

304

2183

1.44

7.80

1.4

1.3

24.69

23.96

iu/l

0.13

257

1879

(3019420) Tryptase [Mass/volume] in Serum or Plasma

144

2.73

7.77

2.1

1.6

14.31

7.38

ug/l

0.34

123

(3003740) Influenza virus B Ag [Presence] in Specimen

498

1.90

7.68

1.1

—

(4200892) Spirometry reversibility

190

1241

1.57

7.68

1.4

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2128

20022

1.35

7.67

4.2

3.5

5.79

5.60

mmol/l

6.26

1977

18674

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

370

2761

1.40

7.64

1.7

1.6

1.39

1.31

1.74

328

2481

(3002523) Influenza virus A Ag [Presence] in Specimen

499

1.90

7.64

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

236

1632

1.49

7.34

2.5

2.3

17.32

23.09

au/ml

0.52

159

(3009214) Lutropin [Units/volume] in Serum or Plasma

151

945

1.63

7.30

1.3

11.47

11.14

u/l

0.07

116

777

(3002256) Pathology report gross observation

355

2658

1.39

7.17

1.3

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

128

2.76

7.12

3.1

2.7

37294.55

40096.56

ug/l

0.69

128

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

216

1477

1.50

7.10

2.6

2.1

0.23

0.22

g/l

0.73

201

1393

(4062490) Immunoglobulin typing, IgG

218

2.32

7.09

1.5

1.4

—

(3021589) Normoblasts [#/volume] in Blood

1100

9607

1.25

7.08

11.1

7.7

0.00

e9/l

1.29

878

7901

(3007566) Smooth muscle Ab [Titer] in Serum

512

1.85

7.08

1.4

1.2

88.89

96.28

titre

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

378

1.99

7.04

1.7

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

114

669

1.74

7.02

1.2

1.6

—

9.38

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

484

3823

1.33

6.91

1.7

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

599

4880

1.30

6.81

1.7

1.6

1.34

1.31

mmol/l

0.30

519

4227

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

204

2.33

6.75

1.8

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

405

1.93

6.75

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

205

2.32

6.68

1.8

1.3

—

(1616796) Gas panel - Central venous blood

303

2.07

6.68

3.8

2.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

220

2.25

6.52

1.5

1.4

3.14

2.96

g/l

0.28

156

(3024139) IgG subclass 3 [Mass/volume] in Serum

220

2.25

6.52

1.5

1.4

0.41

0.38

g/l

0.25

155

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

354

1.98

6.51

1.2

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

176

1174

1.54

6.51

4.2

3.4

71.31

72.26

ng/l

0.07

152

1050

(3027135) IgG subclass 1 [Mass/volume] in Serum

221

2.24

6.46

1.5

1.4

6.41

6.60

g/l

0.15

157

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

413

1.89

6.39

1.8

2.2

165.99

199.65

ug/l

0.27

360

(4146454) Self-monitoring of blood glucose

108

2.80

6.32

2.3

2.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

105

622

1.72

6.29

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

205

2.27

6.25

1.8

1.3

—

(3011288) Drugs identified in Urine by Screen method

158

1039

1.55

6.24

8.0

2.7

—

(40761535) Cells panel - Urine sediment

201

1395

1.48

6.16

4.0

3.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

209

2.22

5.98

1.8

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

209

1471

1.46

5.97

3.3

2.6

1.69

1.75

0.42

186

1299

(3045414) Leukocytes [Presence] in Urine

151

995

1.55

5.93

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

542

1.74

5.92

1.7

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

220

1567

1.44

5.90

1.8

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

211

2.20

5.85

2.7

1.76

1.41

0.33

193

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

2.73

5.85

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

404

1.86

5.84

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

326

1.96

5.84

2.6

2.2

130.20

129.51

g/l

0.09

252

(3024522) Salmonella sp identified in Specimen by Organism specific culture

206

2.21

5.76

1.9

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

206

2.21

5.76

1.8

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

3.25

5.72

23.8

27.9

117.73

103.32

ug/l

0.54

(3027273) Bicarbonate [Moles/volume] in Venous blood

578

1.70

5.71

4.3

2.6

25.29

mmol/l

0.00

561

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

111

686

1.65

5.70

1.3

1.4

20.75

21.98

u/l

0.15

592

(3024980) IgG subclass 4 [Mass/volume] in Serum

322

1.95

5.70

1.5

1.6

0.68

0.65

g/l

0.09

246

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

295

1.99

5.66

2.7

83.82

103.41

ug/min

0.14

191

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

108

665

1.65

5.63

2.4

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

225

1626

1.42

5.59

2.3

2.8

48.39

44.80

u/ml

0.06

215

1571

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

8.49

5.55

1.1

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

229

1663

1.41

5.53

2.8

2.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

153

1028

1.52

5.51

2.4

2.3

66.30

67.29

g/l

0.92

140

957

(3004119) Hemoglobin [Mass/volume] in Venous blood

120

764

1.60

5.48

3.9

2.6

130.30

129.48

g/l

0.17

115

745

(3022621) pH of Urine by Test strip

196

1386

1.45

5.48

3.3

2.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

2.63

5.48

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

533

1.71

5.44

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.97

5.41

2.2

1.9

160.71

146.59

e6/l

0.14

(21494814) CD8 cells/100 lymphocytes in Specimen

3.03

5.37

1.9

2.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

401

1.82

5.37

1.4

1.3

0.95

1.57

nmol/l

4.34

341

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

287

1.97

5.36

1.1

1.3

—

124.00

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

447

1.77

5.30

1.2

1.1

23.95

9.47

au/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

127

827

1.56

5.28

2.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

585

1.67

5.23

1.9

2.1

1.33

1.39

g/l

0.19

517

(4035726) Immunohistochemistry procedure

209

1509

1.42

5.23

1.5

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

450

1.76

5.18

1.8

2.1

2.79

2.96

g/l

0.97

421

(3037121) Protein [Mass/volume] in Urine

556

1.68

5.18

2.5

2.9

0.24

0.34

g/l

0.90

209

(3021387) Prolactin [Units/volume] in Serum or Plasma

223

1634

1.40

5.13

1.6

295.03

314.47

mu/l

0.37

196

1441

(3020491) Glucose [Moles/volume] in Blood

171

2.24

5.10

2.4

1.5

7.41

5.98

mmol/l

1.19

135

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

218

1597

1.40

5.02

1.9

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

126

829

1.55

5.02

2.2

2.1

39.46

38.81

u/l

0.15

121

765

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

192

2.15

5.01

1.8

1.9

14.86

23.39

mg/l

—

(3020779) Urea [Moles/volume] in Serum or Plasma

155

1067

1.48

5.00

8.6

6.9

6.86

7.29

mmol/l

0.42

146

1028

(3000492) Spirometry study

278

2122

1.35

4.97

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

110

706

1.58

4.89

1.1

3.33

2.97

u/ml

0.13

337

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

121

794

1.55

4.89

1.1

2.26

5.31

u/ml

1.06

134

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

113

730

1.57

4.89

1.8

1.6

0.57

0.31

iu/ml

0.23

130

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

429

1.75

4.86

1.9

2.1

9.40

10.13

g/l

0.99

399

(3002385) Erythrocyte distribution width [Ratio]

2090

19915

1.25

4.86

17.9

12.1

14.55

14.28

1.46

2065

19546

(3008898) HLA-B27 [Presence]

163

1143

1.45

4.79

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

469

1.71

4.77

1.8

2.0

7.30

7.45

g/l

0.33

440

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

469

1.71

4.77

1.8

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

469

1.71

4.77

1.8

2.0

3.45

3.56

g/l

0.41

440

(3021901) Oxygen saturation in Capillary blood

203

2.09

4.75

3.0

2.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

136

923

1.50

4.71

2.1

2.8

112.91

126.89

ng/l

0.25

115

821

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

252

1.96

4.69

1.1

1.2

—

0.45

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

450

1.71

4.65

1.1

1.44

2.98

u/ml

1.45

259

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

166

2.19

4.59

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

599

1.61

4.57

2.3

1.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

123

2.37

4.48

1.1

1.0

6.90

8.44

u/ml

—

(3023520) Reticulocytes [#/volume] in Blood

149

1042

1.46

4.46

2.7

2.6

69.26

72.42

e9/l

0.54

111

765

(3017181) Myelocytes/100 leukocytes in Blood

214

1597

1.37

4.43

5.3

4.1

0.85

1.05

0.48

432

(3036180) Methadone [Presence] in Urine

137

2.28

4.38

4.5

3.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

122

824

1.50

4.35

2.3

2.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.66

4.32

1.3

1.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.60

4.30

1.6

1.4

127.87

141.42

mmol/24h

0.55

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

3.96

4.29

1.1

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

438

1.69

4.28

1.2

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

602

1.58

4.26

1.1

0.62

1.00

u/ml

0.61

256

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

312

1.81

4.24

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

312

1.81

4.24

1.4

1.3

—

(3012501) Base excess in Blood by calculation

312

1.81

4.24

4.3

2.8

1.90

2.26

mmol/l

0.56

195

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.63

4.23

1.5

16.17

21.00

u/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

112

748

1.52

4.22

1.8

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

121

2.33

4.17

1.5

1.4

5.72

5.69

u/l

0.01

103

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

503

1.63

4.17

1.3

1.2

224.54

247.95

u/ml

0.42

328

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

109

727

1.52

4.14

1.3

30.54

31.41

u/ml

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

256

1986

1.32

4.12

5.2

4.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.72

4.08

1.9

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.72

4.08

2.0

1.5

—

(3010421) pH of Blood

376

1.72

4.07

4.8

2.7

7.42

0.08

339

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

223

1.94

4.06

1.5

1.4

463.81

364.75

pmol/l

0.58

198

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

141

997

1.44

4.01

1.7

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.02

4.00

2.0

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.90

3.99

3.2

3.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

605

1.56

3.97

1.1

2.13

1.53

u/ml

0.16

290

(3002179) Metamyelocytes/100 leukocytes in Blood

197

1480

1.36

3.94

5.1

3.9

0.58

0.73

0.45

380

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

527

1.59

3.93

1.4

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

164

2.09

3.92

1.2

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

412

1.67

3.88

1.7

2.3

0.11

0.54

g/l

2.07

372

(3004716) Salmonella sp identified in Stool by Organism specific culture

216

1652

1.34

3.84

1.3

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

638

1.52

3.74

1.1

7.27

6.04

u/ml

0.25

344

(3024928) Oxygen saturation in Venous blood

266

1.82

3.74

2.1

2.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

230

1.88

3.74

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

296

1.77

3.71

4.0

3.6

24.85

37.18

mg/l

0.62

243

(40767503) Oxygen content in Capillary blood by calculation

267

1.81

3.70

2.9

2.3

16.64

16.41

0.20

130

(40761536) Microorganisms panel - Urine sediment

257

2026

1.30

3.69

5.5

3.3

—

(3016018) Differential panel - Cerebral spinal fluid

231

1.88

3.69

1.1

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

130

921

1.43

3.69

2.5

2.0

3.17

5.71

ug/l

2.91

108

817

(3021440) Promyelocytes/100 leukocytes in Blood

201

1531

1.34

3.69

5.5

4.2

0.06

0.13

1.26

364

(3042517) Benzodiazepines panel - Urine

3.84

3.69

4.6

2.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

657

1.51

3.67

1.3

2.47

10.38

u/ml

1.89

117

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

132

940

1.43

3.64

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

190

1.96

3.63

1.0

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.41

3.62

1.9

1.7

0.22

0.67

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.41

3.62

1.9

1.7

4.40

2.63

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.41

3.62

1.9

1.7

9.62

0.58

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.41

3.62

1.9

1.7

2.66

3.85

mg/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

156

2.06

3.61

4.1

2.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

248

1.83

3.58

1.7

1.2

4.61

6.00

umol/l

1.67

233

(3023430) Cat dander IgE Ab [Units/volume] in Serum

485

1.58

3.55

1.1

5.99

4.21

u/ml

0.37

191

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

264

1.79

3.52

1.7

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

264

1.79

3.52

1.7

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

647

1.50

3.52

1.3

4.85

7.35

u/ml

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

109

754

1.47

3.52

2.3

4.48

4.75

umol/l

0.11

556

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

165

2.01

3.49

1.1

1.2

53.30

65.80

u/l

0.89

153

(3034860) Kappa light chains.free [Mass/volume] in Serum

295

1.74

3.47

4.0

3.6

28.78

53.27

mg/l

1.02

242

(3004616) Nuclear Ab [Presence] in Serum

273

1.77

3.46

1.4

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

139

2.10

3.43

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

365

1.66

3.41

1.8

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

2.35

3.41

1.1

1.3

143.64

250.76

u/l

1.25

(1002224) Polysomnography panel

129

927

1.41

3.41

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

115

810

1.44

3.39

1.9

2.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.51

3.37

3.2

2.4

155.29

177.35

umol/l

0.12

(3027923) C peptide [Moles/volume] in Serum or Plasma

2.42

3.30

2.1

2.2

1.05

1.52

nmol/l

1.36

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

256

1.77

3.26

1.9

1.6

—

(3045424) Erythrocytes [Presence] in Urine

339

1.67

3.26

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

433

1.59

3.24

1.1

1.0

0.02

0.22

u/ml

1.68

108

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

309

1.70

3.24

2.3

2.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.68

3.22

1.8

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.68

3.22

1.8

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

5.35

3.19

1.0

1.3

5.50

15.17

pmol/l

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

182

1398

1.32

3.19

4.3

2.9

1.23

mmol/l

0.38

156

1203

(3016502) Oxygen saturation in Arterial blood

161

1215

1.35

3.18

6.1

7.1

96.56

96.31

0.34

156

1175

(3008757) Leukocyte morphology finding [Identifier] in Blood

137

2.06

3.16

2.9

3.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

2.74

3.15

1.3

1.8

1.71

1.70

ug/l

—

(3035637) Corticotropin [Mass/volume] in Plasma

237

1.78

3.13

1.8

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

2.42

3.13

1.2

1.4

—

320.00

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

374

1.62

3.13

1.8

2.0

39.31

38.55

g/l

0.77

345

(3017509) Phencyclidine [Presence] in Urine

3.44

3.10

2.7

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

478

1.54

3.10

1.2

1.5

3227.48

8991.57

e6/l

0.32

389

(3025159) Blasts/100 leukocytes in Blood

190

1475

1.31

3.09

5.7

4.2

0.00

0.61

0.94

306

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

105

2.20

3.09

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

479

1.54

3.07

1.2

1.4

23.96

22.69

e6/l

0.04

366

(3006462) Nitrate [Presence] in Urine

112

2.15

3.06

2.3

2.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

197

1542

1.30

3.02

1.4

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

182

1.88

3.00

1.6

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

175

1.90

3.00

4.2

2.9

2.52

35.86

nmol/l

0.53

169

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

147

1.98

3.00

1.6

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

580

1.48

2.99

1.2

1.3

31.44

38.85

u/ml

—

(3042631) Mycobacterium sp identified in Specimen

134

2.03

2.96

2.7

2.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

176

1.89

2.95

1.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

121

2.08

2.92

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

121

2.08

2.92

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

121

2.08

2.92

1.8

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

413

1.56

2.91

2.1

2.0

2.06

1.49

ug/l

0.29

366

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.22

2.89

2.8

3.0

9.58

7.12

mg/l

1.05

(3023420) DNA double strand Ab [Units/volume] in Serum

266

1.70

2.89

1.8

1.6

17.80

23.93

iu/ml

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.70

2.88

1.5

2.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

367

1.59

2.87

1.9

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

207

1.80

2.87

2.6

2.3

56.41

63.08

1.11

207

(40760888) Immunoglobulin light chains.free panel - Serum

223

1.76

2.82

4.4

3.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.34

2.81

1.8

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

130

2.01

2.80

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

490

1.50

2.80

1.3

1.2

—

6.23

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

239

1.73

2.78

1.8

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

475

1.51

2.77

1.5

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.37

2.72

1.3

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

397

3401

1.20

2.72

2.1

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.60

2.70

3.4

3.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

132

1.98

2.70

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.51

2.70

1.9

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

265

1.67

2.66

1.9

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

637

1.43

2.65

2.6

2.5

3.53

3.55

g/l

0.06

605

(3022689) Creatine [Moles/volume] in Urine

2.80

2.64

1.8

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

464

1.50

2.64

1.1

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

336

1.59

2.63

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.16

2.61

1.4

1.5

9.92

6.02

u/l

0.33

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.61

2.57

2.4

1.8

—

(3003396) Base excess in Arterial blood by calculation

179

1417

1.28

2.56

5.9

6.6

0.64

0.89

mmol/l

0.51

145

1096

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.74

2.54

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

172

1357

1.29

2.53

2.8

3.8

3.12

37.28

ug/l

0.72

125

998

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

194

1.76

2.50

1.1

1.2

1.38

1.75

u/ml

0.14

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

136

1.92

2.50

2.7

2.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.67

2.45

1.8

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.67

2.45

1.8

1.2

—

(3023419) Bacteria identified in Sputum by Culture

166

1.82

2.45

2.2

2.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

180

1435

1.27

2.45

2.6

2.3

70.49

76.20

ml/min/173m2

0.83

543

(3012494) Peanut IgE Ab [Units/volume] in Serum

103

2.05

2.41

1.1

9.55

3.99

u/ml

0.38

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

103

2.05

2.41

1.1

1.0

96.73

94.05

0.29

(3014133) Dog dander IgE Ab [Units/volume] in Serum

532

1.44

2.41

1.2

1.0

5.14

3.57

u/ml

0.25

248

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

258

1.64

2.39

1.2

—

36.40

—

(3020891) Body temperature

483

1.46

2.39

4.1

4.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.26

2.37

5.6

2.3

—

(3007463) Buprenorphine [Presence] in Urine

3.64

2.36

7.8

3.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.10

2.32

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.19

2.31

1.3

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.22

2.30

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.46

2.27

1.1

1.2

0.47

0.23

u/ml

0.32

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.49

2.27

1.6

1.7

—

(40768441) Liver Pathology biopsy report

127

1.90

2.26

1.6

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

583

1.40

2.23

2.5

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

644

1.38

2.20

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.41

2.19

4.4

2.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

149

1180

1.28

2.17

1.7

1.6

3.89

4.21

mg/l

0.16

102

826

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

177

1432

1.25

2.16

1.3

248.89

239.09

miu/ml

0.12

733

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.69

2.15

4.0

7.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

266

1.59

2.15

1.3

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.01

2.14

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

120

925

1.31

2.14

1.4

1.3

2.60

3.89

ug/l

2.33

109

866

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.63

2.14

1.5

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

243

1.61

2.13

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.11

2.12

1.2

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

438

1.45

2.10

1.4

1.5

—

(3008295) Osmolality of Serum or Plasma

160

1.76

2.09

1.7

1.6

291.50

280.70

mosm/kgh2o

2.93

126

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.21

2.09

3.1

3.3

—

10.88

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

381

1.48

2.09

2.9

2.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

131

1.84

2.08

1.2

110.00

185.52

titre

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

357

1.49

2.07

3.3

2.1

—

(3019060) Gas panel - Arterial blood

746

1.34

2.07

3.5

5.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.26

2.07

1.7

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

161

1.75

2.06

3.6

5.4

7.55

6.56

mmol/l

0.61

130

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

103

1.95

2.05

1.2

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

104

792

1.33

2.03

7.4

7.6

94.15

94.35

0.20

104

787

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

162

1.74

2.02

2.0

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.23

2.01

3.1

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.64

2.00

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.97

2.00

1.1

98.80

97.10

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

226

1896

1.21

1.98

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

436

1.43

1.97

4.6

3.6

58.13

57.36

0.18

436

(3000330) Specific gravity of Urine by Test strip

116

902

1.30

1.97

3.9

2.7

—

(3024869) Neuronal Ab [Presence] in Serum

3.34

1.96

1.4

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.03

1.95

1.1

—

(40765096) Chromosome analysis panel by Banding

2.57

1.94

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

219

1.61

1.91

2.2

1.4

60.60

64.69

mmol/l

0.25

181

(3014599) Egg white IgE Ab [Units/volume] in Serum

235

1.58

1.90

1.1

1.0

3.06

3.24

u/ml

0.02

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.16

1.88

1.1

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.19

1.88

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.31

1.87

2.3

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

129

1.79

1.85

1.3

1.2

60.91

70.14

umol/l

2.50

129

(43055514) Macroprolactin [Presence] in Serum or Plasma

122

1.81

1.84

1.2

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.53

1.83

1.2

97.05

111.36

ng/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

175

1.66

1.82

1.1

4.58

9.37

iu/ml

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

649

1.34

1.82

7.8

9.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

183

1.65

1.82

1.3

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

385

1.44

1.81

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

352

1.46

1.81

1.2

1.1

115.39

1414.04

iu/ml

0.51

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.05

1.80

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

223

1890

1.20

1.77

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.17

1.77

1.8

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

131

1.76

1.77

1.6

1.5

42.00

38.99

0.11

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

224

1900

1.20

1.77

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

224

1901

1.20

1.76

1.5

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.34

1.74

1.8

1.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

448

1.39

1.73

1.6

1.3

109.84

106.72

u/ml

0.11

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.92

1.72

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

125

1.77

1.72

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

226

1.56

1.70

1.2

1.1

2.83

2.55

u/ml

0.03

(3036071) Salmonella sp Ab [Titer] in Serum

1.92

1.70

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

228

1.54

1.65

1.2

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.80

1.65

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.80

1.65

1.0

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.58

1.61

1.0

2.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.07

1.59

1.2

1.0

9.56

1.73

u/ml

0.80

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

159

1.64

1.59

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

3.00

1.58

2.0

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.00

1.58

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.70

1.58

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

191

1.58

1.57

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.58

1.57

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.58

1.57

1.3

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

223

1.53

1.57

1.1

274.83

202.12

mg/l

1.04

192

(3036489) Thrombin time

101

799

1.27

1.56

2.3

2.1

20.36

20.75

0.56

670

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

640

1.31

1.55

2.9

2.5

164.48

164.88

0.02

612

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.11

1.55

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

192

1.57

1.54

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

192

1.57

1.54

1.3

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

273

1.47

1.54

1.1

1.5

—

(40768793) Breast Pathology biopsy report

721

1.29

1.53

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

528

1.33

1.53

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.56

1.51

1.3

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

123

1.71

1.50

1.4

1.6

1.14

3.86

nmol/l

0.87

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.16

1.50

1.8

4.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

154

1.63

1.50

1.4

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

536

0.69

1.49

1.7

1.6

7.29

7.57

mmol/l

0.37

514

(3025018) Bordetella pertussis Ab [Titer] in Serum

162

1.61

1.49

1.2

—

(3028433) Virus identified in Specimen by Culture

2.01

1.48

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

202

1.54

1.48

1.9

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

429

1.36

1.45

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.50

1.45

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

361

1.39

1.44

5.4

3.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.13

1.44

5.0

10.2

6.50

5.92

mmol/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.13

1.44

1.0

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

156

1.61

1.43

29.0

18.9

1554.96

1609.13

nmol/l

0.12

151

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.04

1.43

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

212

1.52

1.43

3.8

2.9

—

(44813793) Dust mix specific IgE antibody measurement

212

1.52

1.43

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.31

1.43

1.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

213

1.51

1.40

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.38

1.1

—

(40768446) Kidney Pathology biopsy report

2.00

1.38

1.8

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

256

1.45

1.36

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

159

1.58

1.34

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

232

1.47

1.34

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

153

1.57

1.28

2.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.78

1.28

2.8

2.4

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.78

1.28

1.4

1.3

—

10.16

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.94

1.27

1.2

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

2.29

1.26

1.1

9.5

—

(3021788) Differential panel - Synovial fluid

286

1.40

1.25

1.5

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

211

1.47

1.25

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.00

1.23

1.1

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

163

1.54

1.23

1.7

1.4

9.92

9.74

umol/l

0.04

150

(3003694) ABO and Rh group [Type] in Blood

834

7871

1.09

1.22

1.8

1.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.63

1.21

1.0

1.1

—

55.22

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.63

1.21

2.8

2.4

25.80

17.30

mg/l

—

(3009871) Measles virus Ab [Titer] in Serum

1.80

1.21

1.6

1.8

—

(3037756) Immunofixation for Serum or Plasma

213

1.46

1.20

2.6

1.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

156

1.54

1.20

2.0

1.6

14.70

24.13

umol/l

1.87

148

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

205

1.47

1.20

1.1

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

101

1.69

1.19

1.1

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.31

1.18

1.8

3.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.31

1.18

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.31

1.18

1.2

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

109

1.66

1.18

2.9

2.7

47.90

48.41

—

(3050129) First trimester maternal screen panel - Serum or Plasma

266

2371

1.14

1.17

1.6

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

215

1.45

1.16

1.0

0.17

0.23

u/ml

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

110

1.64

1.15

1.2

1.0

12.50

15.00

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.73

1.09

1.3

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

1.95

1.08

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

120

1.59

1.08

3.1

3.2

31.46

47.29

mg/l

0.26

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

185

1.46

1.08

1.8

1.7

49.88

53.23

0.16

109

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

203

1.43

1.05

1.1

—

55.89

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.96

1.03

1.4

—

(3051651) Icteric interference index of Serum or Plasma

1.64

1.03

3.4

2.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

179

1.46

1.03

1.7

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.84

1.02

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.84

1.02

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

326

1.32

0.99

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

394

3631

1.10

0.99

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

181

1.44

0.98

1.2

1.3

—

(3016750) Collection duration of Urine

1.67

0.97

2.6

2.4

506.22

506.42

min

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

1.38

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

190

1.43

0.96

1.5

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

190

1.43

0.96

1.5

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

100

1.60

0.96

1.9

1.6

123.13

137.11

0.42

(3017704) Immunofixation for Urine

1.80

0.96

1.1

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

224

1.39

0.96

1.6

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.77

0.94

1.3

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.77

0.94

1.3

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.77

0.94

1.3

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

418

1.27

0.93

1.2

4.06

3.55

u/ml

0.08

143

(3000475) Leukocytes [#/volume] in Synovial fluid

339

1.30

0.92

1.8

1.7

5832.21

11368.72

e6/l

1.21

240

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.15

0.91

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

193

1.40

0.90

1.7

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

185

1.41

0.89

1.7

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

493

1.24

0.88

1.7

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

254

1.34

0.88

1.4

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

103

1.56

0.87

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

103

1.56

0.87

1.9

1.5

—

(3042733) HLA Ab [Presence] in Serum

1.86

0.87

4.5

4.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

144

1.46

0.87

1.1

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

230

1.35

0.84

1.7

1.6

—

(3045142) Bone marrow Pathology biopsy report

145

1.45

0.84

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

265

1.33

0.84

1.6

1.4

—

(3011648) Oxygen content in Venous blood

1.57

0.84

2.8

2.2

10.54

11.13

0.19

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

162

1.42

0.84

1.1

1.28

1.04

u/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.78

0.84

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

281

2573

1.10

0.83

1.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

119

1033

1.16

0.82

1.9

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

227

2060

1.11

0.80

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.73

0.79

3.0

2.7

63.00

152.88

ng/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.82

0.79

1.7

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.67

0.78

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.67

0.78

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.67

0.78

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.67

0.78

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.67

0.78

2.8

1.5

8.63

7.52

ug/l

0.71

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.77

0.76

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

176

1.37

0.72

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.75

0.71

1.3

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.58

0.71

1.0

1.1

—

(3003338) MCHC [Mass/volume]

2030

20007

1.07

0.70

18.6

12.8

332.09

331.68

g/l

1.44

2019

19847

(3004775) Volume in Urine collected for unspecified duration

102

1.47

0.67

2.7

2.4

798.33

595.51

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.63

0.66

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

155

0.64

0.65

1.2

1.54

1.62

g/l

—

155

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.57

0.65

1.2

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.62

0.65

2.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.62

0.65

2.2

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

103

1.46

0.65

3.8

4.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

242

1.28

0.64

2.8

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

163

1.35

0.64

2.9

3.5

0.78

0.80

nmol/l

0.10

130

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.48

0.64

1.4

77.46

84.10

nmol/24h

0.14

(4281824) Cell count and differential, peritoneal fluid

243

1.28

0.62

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

190

1.32

0.62

1.1

1.05

1.04

ratio

—

(4034850) Laboratory test

646

1.17

0.62

9.2

7.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

406

1.21

0.62

1.1

1.2

3.21

4.67

u/ml

0.56

164

(3015183) Erythrocyte sedimentation rate

176

0.68

0.62

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

182

1.32

0.61

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

2.00

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.57

0.60

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

381

1.21

0.59

3.7

3.1

23.34

22.61

mg/l

0.03

235

(3035933) Granulocytes/100 leukocytes in Blood

1.45

0.59

1.2

1.4

—

(3001556) Androgen free Index in Serum or Plasma

1.48

0.57

1.0

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.48

0.57

1.1

—

0.19

g/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

144

1585

0.90

0.56

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

141

1.35

0.56

4.2

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.62

0.55

2.3

—

(3014271) Vancomycin [Susceptibility]

1.62

0.55

3.3

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.62

0.55

2.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

133

1.36

0.55

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.42

0.54

1.4

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.54

0.53

1.2

—

(3020650) Glucose [Presence] in Urine

1.49

0.49

1.3

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.49

0.49

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

224

2092

1.08

0.48

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

1.40

0.48

1.5

127.08

125.27

nmol/l

0.06

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

226

1.24

0.48

2.1

3.5

18.45

43.36

u/ml

2.13

226

(3024471) HLA-A [Type]

1.46

0.46

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.46

0.46

1.0

1.1

—

(3024932) HLA-DR beta [Type]

1.46

0.46

1.3

1.1

—

(3044927) Protein electrophoresis panel - Urine

1.38

0.46

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.43

0.45

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

228

1.23

0.45

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

1.37

0.44

1.9

2.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

734

1.12

0.44

1.8

2.1

3.46

4.40

iu/l

0.50

298

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

187

1745

1.08

0.43

1.5

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

131

1.30

0.42

1.4

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

140

1.29

0.42

3.2

2.6

1.62

1.17

g/24h

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

140

1.29

0.42

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.52

0.41

1.4

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.19

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.41

0.0

1.1

—

6.36

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.08

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

114

1.32

0.40

1.0

1.3

—

76.60

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.33

0.40

1.4

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.41

0.39

2.4

1.5

—

(3044941) Cell count panel - Synovial fluid

243

1.20

0.37

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.29

0.36

2.6

1.5

—

(3024263) Appearance of Synovial fluid

1.29

0.36

1.2

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

124

0.72

0.35

1.2

—

(3004451) EKG impression Narrative

1.40

0.35

1.5

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

192

1814

1.06

0.34

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

387

1.14

0.33

1.1

115.21

119.32

0.39

349

(21494890) Protein electrophoresis panel - 24 hour Urine

109

1.29

0.33

2.4

1.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

378

1.14

0.33

1.4

—

(3035880) pH of Pleural fluid

1.28

0.32

1.2

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.31

0.31

2.0

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

119

1.26

0.31

1.6

1.8

1.63

2.18

u/field

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.27

0.30

2.3

2.4

14.90

16.70

umol/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

194

1.19

0.29

2.1

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.67

0.25

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

444

1.11

0.25

2.7

3.1

246.13

471.74

u/ml

0.27

373

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

870

0.93

0.24

1.2

—

(3045788) Cell count panel - Pleural fluid

0.72

0.24

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

131

1381

0.95

0.23

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

304

1.12

0.22

3.7

4.4

277.45

72.18

u/ml

0.68

(3005033) Fetal Nuchal fold Thickness US

161

1538

1.05

0.22

1.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.19

0.21

1.0

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.1

—

10.54

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.21

0.0

2.7

—

375.82

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.1

—

42.03

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.21

0.0

1.1

—

0.10

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

2.24

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.1

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.2

—

4.38

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.2

—

7.13

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

126

1.19

0.21

1.9

1.4

296593.10

32439.00

e6/l

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.13

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

291.23

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

412

1.09

0.20

1.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.20

0.0

7.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.20

0.0

1.1

—

8.19

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.24

0.18

2.4

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

467

0.92

0.18

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

132

0.83

0.18

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.19

0.18

1.0

1.1

—

78.33

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.17

0.17

1.0

1.1

—

75.67

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

160

1542

1.04

0.17

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

330

1.09

0.17

4.4

3.9

0.27

0.37

u/ml

1.81

187

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

495

0.93

0.16

1.6

1.5

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.11

0.15

1.2

1.6

159.22

190.23

u/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

129

0.85

0.14

1.3

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

164

1589

1.03

0.14

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

480

0.94

0.13

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

170

1.12

0.13

3.9

3.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.16

0.11

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.09

0.09

1.2

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

272

1.07

0.09

2.2

2.3

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.09

0.09

3.0

1.7

18.45

18.17

umol/l

—

(21494434) Karyotype in Bone marrow

107

1.12

0.08

1.1

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.08

0.08

1.0

2.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

156

1.09

0.08

2.3

2.1

32.88

30.98

1.32

156

(3034426) Prothrombin time (PT)

0.84

0.07

1.0

1.2

—

(3012441) Differential panel - Pleural fluid

0.83

0.07

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.11

0.06

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

158

1.08

0.06

6.1

7.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

129

1.09

0.05

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

764

1.02

0.04

1.5

0.62

0.47

nmol/l

0.39

628

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

160

0.94

0.04

1.1

1517.54

1491.29

miu/ml

0.03

160

(3000012) Reticulocyte production index

169

0.95

0.03

2.4

2.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

108

0.93

0.03

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

117

0.94

0.01

1.8

2.2

25.81

87.00

ug/l

0.47

110

(3041806) Other cells [#/volume] in Blood by Manual count

197

0.96

0.01

1.5

—

(21494755) Public health laboratory ask at order entry panel

308

3089

1.00

0.01

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

155

1.03

0.00

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

121

0.99

0.00

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

161

0.99

0.00

1.1

—

30.80

u/ml

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

106

1.04

0.00

1.1

—

(1761868) Lipid panel - Serum or Plasma

838

8377

1.00

0.00

2.5

2.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

11.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.95

-0.00

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

187.40

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

176.20

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

2.39

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3047189) Immunofixation for 24 hour Urine

0.94

-0.00

4.0

1.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.91

-0.00

1.1

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_VULVOVAGINFINOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_VULVOVAGINFINOTH	1.303 [1.09, 1.56]	0.004
Birth year	0.996 [0.99, 1.0]	0.405

During the follow-up period (1.1.1998 — 31.12.2019), 476 out of 10556 females with N14_VULVOVAGINFINOTH died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_VULVOVAGINFINOTH.

N-year risk	Females	Males
1	0.112%	No data
5	0.75%	No data
10	1.751%	No data
15	3.739%	No data
20	6.78%	No data

Relationships between endpoints

↥

Index endpoint: N14_VULVOVAGINFINOTH – Vulvovaginal ulceration/inflammation in other diseases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Vulvovaginal ulceration/inflammation in other diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints